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ABSTRACT 
 
Understanding allostery in proteins is critical in understanding their 
unique regulatory mechanisms and this knowledge can be exploited to 
develop highly specific, targeted therapies. In this dissertation, we have 
investigated the unique sequence elements that regulate the activity of a 
protein tyrosine kinase called Bruton’s tyrosine kinase or Btk. Btk is a member 
of the immune signaling pathway in B-cells and is required for B-cells 
maturation and function.  
 
Lack of a three-dimensional structure of full-length Btk kinase has 
proved a roadblock in understanding how the domains in Btk interact to shift 
its conformational equilibrium between active and inactive states. Moreover, 
in-spite of high homology between the catalytic centers of Btk and other well-
studied protein tyrosine kinases such as Src, the regulatory mechanisms of 
these kinases appear to differ significantly creating an impediment to gaining 
a complete understanding of the mode of Btk regulation.  
 
In pursuit of the aim to identify key sequence and structure motifs that 
regulate Btk activity, we made use of a range of computational tools to better 
understand the Btk kinase domain and, when possible, the resulting 
hypotheses were tested using experimental methods. First, we have identified 
a specific isoleucine residue, conserved in Btk and related kinases, which 
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functions to stabilize the inactive Btk conformation. We showed that 
substitution of the conserved isoleucine to leucine shifts the conformational 
equilibrium of the Btk kinase domain to the active state. Next, we showed how 
a highly conserved tryptophan, located in a linker region adjacent to the Btk 
kinase domain, stabilizes the active Btk kinase domain conformation through 
correlated dynamic motions within the kinase domain itself. Finally, sequence-
structure information, combined with information theory and molecular 
dynamics, was used to identify a specific site in the Btk kinase domain that 
can be targeted to rescue the kinase activity of Btk in the presence of an 
inactivating disease causing mutation. 
 
The work presented here provides new insights into the regulatory 
mechanisms in Btk as well as potential allosteric sites in the protein, for which 
modulators of Btk activity could be developed.  There is a growing need for 
the discovery of such allosteric modulators as Btk has been implicated in 
immunodeficiency disorders such as X-linked agammaglobulinemia as well as 
B-cells malignancies and breast and colon cancers. Ultimately, increased 
knowledge about the molecular mechanisms controlling Btk function should 
lead to the development of novel Btk activity modulators.   
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CHAPTER 1: GENERAL INTRODUCTION 
  
Literature review 
All cells in living systems need to read and respond to the 
environmental cues to modulate their growth and function. Cell 
responsiveness and communication between them form the basis of a living 
entity and is conferred by various proteins, which participate in signal 
transduction: reading signals from the outside of the cell and transmitting the 
information to the inside of the cell. Enzymes are protein catalysts of 
biological reactions in living cells, which are central to all signaling pathways 
and biological processes. Enzymatic activity or inactivity regulates the flow of 
information through biological pathways and their irregular behavior results in 
diseased states1,2.  
  
Kinases are enzymes that regulate the majority of signal transduction 
pathways in a variety of cells3. There are 518 genes encoding kinases in the 
human genome, and of these, 32 genes encode a class of protein kinases 
called non-receptor protein tyrosine kinases4. These are cytosolic enzymes, 
which catalyze the transfer of a γ-phosphate group from ATP to a tyrosine 
residue on the substrate. Our interest lies in Bruton’s tyrosine kinase (Btk), 
which belongs to the second largest family of non-receptor protein tyrosine 
kinases, and plays a critical role in immune cell signaling4.   
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Bruton’s tyrosine kinase or Btk is one of five related kinases that 
belong to the non-receptor tyrosine kinase family called the Tec kinases. Btk 
is expressed in a variety of immune cells such as B-cells, mast cells, 
platelets, osteoclasts and macrophages4. Btk plays an important role in B-cell 
maturation and function6,7.  It is named after Dr. Ogden Burton who first 
described a genetic disorder called X-Linked Agammaglobulinemia5,6 (XLA), 
which is ascribed to mutations in the btk gene6.  XLA-causing mutations in Btk 
results in loss of its activity, and a significant decrease in the number of 
circulating mature B-cells. The lack of mature B-cells in the blood results in 
the patient being highly susceptible to bacterial infections.  
 
In addition to the immunodeficiency, XLA, Btk is also associated with a 
number of immune cell cancers. For this reason, Btk is increasingly targeted 
by the pharmaceutical industry in the context of B cell malignancies8,9,10. 
Beneficial clinical responses11 have been achieved12 with drugs such as 
ibrutinib, in treating chronic lymphocytic leukemia, mantle cell lymphoma, and 
Waldenstrom’s macroglobulinemia13. Beyond B cell malignancies, recent 
reports have revealed that isoforms of Btk are expressed in colon and breast 
cancers14.  In all cases, inhibition or down regulation of Btk provides a new 
therapeutic approach toward selective destruction of cancer cells. Despite of 
early success inhibiting Btk in the clinic15,16, it is now clear that malignant cells 
are able to exploit numerous mechanisms that lead to drug 
resistance17,18,19,20,21.  Increasing instances of resistance to Btk inhibitors 
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motivates significant effort to find new ways to target this kinase22. Our efforts 
have focused on improving our understanding of the allosteric regulatory 
mechanisms that control Btk function.  Targeting sites outside of the kinase 
active site is rapidly gaining attention as one strategy to overcome drug 
resistance23.  Understanding Btk regulation at the molecular level should 
therefore reveal new ways to modulate Btk activity.  Ultimately, combination 
therapies that include both active site and non-active site inhibitors should 
increase potency and decrease the cell’s ability to escape inhibition.  
 
A significant hurdle in our efforts to date is the lack of a three-
dimensional atomic level structure of the full-length Btk enzyme. A recent 
structure of the Btk SH3-SH2-Kinase domain fragment in the inactive 
conformation by Wang et al24 has shed some light on the arrangement of the 
domains, which stabilize the inactive state. In the context of limited structural 
data, our objective is to use the available sequence and structural information 
to understand the regulatory mechanism of the Btk kinase domain in order to 
characterize new ways to modulate Btk function. The next section involves a 
detailed description of the role of Btk in B-cell receptor signaling pathway and 
the structural and molecular features of Btk kinase.    
 
Btk in B-cell Receptor signaling 
Btk participates in the signaling pathway downstream of the B-cell 
receptor4,25,26. It is activated by another protein tyrosine kinase, Lyn, which in 
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turn is activated by antigen binding to B-cell receptor. Activation of Btk 
requires phosphorylation of a conserved tyrosine (Y551) on the Btk activation 
loop by the upstream Lyn kinase, followed by subsequent auto-
phosphorylation of Btk, which amplifies its activity. Active Btk leads to PLCγ 
activation on Y753, which hydrolyses phosphatidylinositol-4,5-bisphosphate, 
generating second messengers inositol-1,4,5-trisphosphate (IP3) and di-acyl 
glcerol (DAG). IP3 leads to release of Ca2+ ions from the endoplasmic 
reticulum, while DAG activates protein kinase C (PKC)27,28.  This leads to the 
B cell response, which, in a mature B cell involves antibody production.  
 
As stated earlier, defects in Btk signaling due to XLA mutations lead to 
a significant decrease in the number of circulating mature B-cells, which are 
capable of producing antibodies. There are ~240 separate missense 
mutations recognized to caused XLA. These mutations are spread throughout 
the Btk protein (except the SH3 domain). Loss of Btk activity, due to these 
single amino acid mutations, creates a block in the maturation of pre-B cell 
from the pro-B cell stage5,6,29  (Fig. 1).     
 
Fig. 1: XLA affects B-cell maturation from pro to pre-B cell stage by affecting 
Btk activity (figure adapted from ref 29). 
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Btk architecture 
Btk is a ~76 KDa multi-domain protein30,31  (Fig. 2). It has an N-terminal 
Pleckstrin homology (PH), Tec homology (TH), Src-homology 3 and 2 (SH3 
and SH2) domains, and a C-terminal catalytic Src-homology SH1 or kinase 
domain. The kinase domain is the catalytic domain. 
 
  Fig. 2: Domain architecture of Btk kinase 
 
PH-TH domain 
Pleckstrin homology domains, found in a number of different signaling 
proteins, share low sequence similarity but have a common fold consisting of 
a six/seven stranded antiparallel β sheet and C-terminal α-helix32 (Fig. 3). PH 
domains bind to phosphatidylinositol-3,4,5-trisphosphate, and therefore 
functions to recruit Btk to the membrane. The C-terminus of the PH domain in 
Btk is extended into another structural motif called the Tec homology (TH) 
domain33. It consists of a region called the Btk motif and a proline rich region. 
This motif binds to Zn and serves to maintain PH domain structural integrity.   
PH-TH Kinase SH3 SH2 
PH-TH 
SH3 
SH2 
Kinase 
Pleckstrin Homology-Tec Homology
(3-133 amino acids)
Src Homology 3
(214-274 amino acids)
Src Homology 2
(281-377 amino acids)
Src Homology 1/Kinase domain
(402-659 amino acids)
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Fig. 3: Structural features of PH domain (PDB ID: 1b55) 
 
SH3 domain 
The domain extends from amino acids 214-274 and the structural motif 
is composed of a five-stranded β-barrel structure (Fig. 4). This protein module 
mediates protein-protein interactions, most commonly by binding to target 
proteins through proline-rich sequences34. 
β1β2
β3
β5
β6
α1β4
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     Fig. 4: Structural features of SH3 domain (PDB ID: 4ZNX) 
 
 
 
 
 
 
 
 
 
 
 
 
β1
β2
β3
β4
β5
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SH2 domain 
The Src homology 2 (SH2) domain extends from 281-377 and consists 
of a phosphotyrosine-binding module (Fig. 5) present in many signaling 
molecules. The SH2 domain is located N-terminally to the catalytic kinase 
domain (SH1) where it primarily functions to regulate kinase activity35. 
 
Fig. 5: Structural features of SH2 domain (PDB ID: 1NZV) 
 
 
 
 
 
 
 
α1
β1
β2
β3
α4
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Kinase domain 
The kinase domain extends from amino acids 402-689 and consists of 
a conserved architecture, which is shared among kinase families36,37.  The 
kinase domain consists of two structurally and functionally distinct lobes: the 
smaller N-lobe and larger C-lobe (Fig. 6).  
 
       Fig. 6: Three-dimensional fold of the Btk kinase domain (PDB ID: 3K54)  
 
N-lobe  
The N-lobe of the Btk kinase domain consists of a 5-stranded β sheet 
and a functionally important αC-helix. There exist a number of highly 
conserved sequence motifs37 that are common to the kinase domain core. 
The Gly-loop between β1 and β2, has a conserved GxGxxG consensus 
sequence and it functions to position the γ-phosphate of ATP for catalysis37. 
Another important motif is AxK in the β3 strand, which functions to couple the 
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phosphate of ATP to the αC-helix, via a critical salt bridge formation between 
the conserved K430 on the β3 strand with a conserved E445 residue on the 
αC-helix. The K430 residue positions the α and β phosphates of ATP for 
catalysis. This K430-E445 salt bridge is highly conserved through the entire 
kinase family and is often used as an indicator of the active status of the 
kinase domain (Fig. 6).  
 
The αC-helix is a critical regulatory element in the kinase domain and 
is termed as “signal integration” motif37. The conserved Glu on the αC-helix, 
E445 in Btk, is required for salt-bridge formation with the conserved Lys 
described above. The Lys/Glu (K430-E445 in Btk) salt bridge is formed in the 
‘C-in’ state of the αC-helix. The salt-bridge is broken when the αC-helix 
swings out, which is called the ‘C-out’ state. The switch between the ‘C-in’ 
and ‘C-out’ state of the αC-helix also regulates the positioning of the 
activation segment, which is located at the junction of the N and C-lobe of the 
kinase domain. In the inactive state of the kinase domain, the activation 
segment is coiled within the kinase domain cleft, blocking the active site. The 
αC-helix is displaced from the ‘C-in’ to a ‘C-out’ position in this conformation 
of the activation segment. Phosphorylation of a critical Tyr (Y551-Btk kinase 
domain) residue on the activation loop shifts the equilibrium to the open-loop 
conformation of the activation segment, allowing the αC-helix to swing to ‘C-
in’ state towards the N-lobe. The C-terminus of the αC-helix is anchored to 
the rigid C-lobe. 
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C-lobe  
The kinase domain C-lobe is mainly composed of α-helices and has a 
β-subdomain, comprised of four short β strands 6-9. The G-helix is the site of 
substrate docking41. The C-terminus of the peptide is found to interact with 
P+1 loop, where the residue right after the phosphorylation site is buried in a 
pocket formed by this loop. The catalytic loop between the short β-strands 6-9 
contains the catalytic machinery associated with transfer of the phosphate 
group from ATP to the protein substrate38.  The hydrophobic αF-helix is found 
to be a conserved motif in the kinase family, which serves as a scaffold for 
the assembly of the kinase doamin39. 
 
Activation segment  
The activation segment is considered to be the most important 
regulatory element in protein kinases and its conformation influences both 
substrate binding and catalysis. The activation segment can be subdivided 
into three regions37; the N-terminal region, the activation loop and the C-
terminal region. The N-terminal region contains the DFG motif (DFG = 
AspPheGly), which is critically important for catalysis. In the active “DFG-in” 
state of a kinase domain, the DFG-aspartate binds to a Mg2+ ion, which 
coordinates and positions the γ-phosphate of ATP.  The hydrogen bond 
between DFG-Asp (D539-Btk) and DFG-Gly (G541-Btk) positions the 
aspartate (D539-Btk) side-chain appropriately for Mg2+ binding. The DFG-
phenylalanine (F540-Btk) makes significant hydrophobic interactions with two 
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residues in the αC helix, which stabilizes the ‘C-in’ position in the active 
kinase conformation. In the inactive kinase conformation, the DFG mediated 
interactions are lost and the DFG motif is said to be in the ‘DFG-out’ state. 
The middle region of the activation segment is called the activation loop, 
which is most diverse in terms of length and amino acid sequence among 
protein tyrosine kinases. It has a tyrosine residue (or in some cases Ser/Thr) 
that can be phosphorylated by other protein kinases or auto-phosphorylated. 
The negatively charged phosphate makes hydrogen bonds and functions to 
organize the active site for catalysis. The C-terminus of the activation 
segment begins with the P+1 loop and extends to αEF helix. It ends with a 
conserved APE motif, which stabilizes the activation segment by docking to 
the αF-helix.   
 
Regulatory spine and Catalytic spine  
A set of hydrophobic residues, distributed in both the N- and the C-
lobe, form a Regulatory spine39 (R-spine) or hydrophobic spine in the active 
kinase conformation (Fig. 7). The R-spine is a highly conserved motif, 
involving four residues, found to be far apart in the sequence. The function of 
the R-spine is to properly orient the N-and C-lobe for catalysis in the active 
kinase. The R-spine is found to be disassembled in the inactive kinase 
structure.   
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Another non-consecutive set of residues form the catalytic spine39 (C-
spine) (Fig. 7). The C-spine consists of seven residues, which are distributed 
in both the lobes. The catalytic C-spine is fully assembled by the adenine ring 
of ATP. The function of this spine is to arrange the residues important for 
catalysis in the active state.  
	    
Fig. 7: The residues forming the Regulatory and catalytic spines (assembled 
state) shown on Btk kinase domain (PDB ID: 3K54) 
 
 
Motivation  
 
The kinase domain of Tec family members share similar structural 
features with other protein tyrosine kinases, such as the activation segment, 
αC-helix, Gly loop, catalytic loop. The Regulatory spine and the catalytic spine 
residues are also fully conserved among protein tyrosine kinases.  However, 
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in-spite of these conserved features, the Tec family kinases are regulated in a 
manner completely opposite from other well-studied non-receptor protein 
tyrosine kinases such as the Src family of kinases. As a case in point, the 
kinase domain of the Src kinase is fully active while the corresponding kinase 
domain of Btk and related Tec family members is inactive.  This finding implies 
that there are significant differences between the Tec and Src family kinases 
that leads to different activity profiles. The differences in regulation of these 
two kinases is not apparent by looking at the static crystal structures of the Src 
and Tec family kinase domains as they share similar backbone conformations 
throughout. Activity assays have suggested that the Btk kinase domain is 
active when the kinase domain is extended in the N-terminal direction to 
include W395 in the SH2-kinase linker region 40 (Fig. 8a,b). Crystal structures 
of the active kinase domain fragments of the Tec family that include this 
extension into the SH2-kinase linker region, capture the active state of the 
kinase domain (Fig. 8c). However, the Btk kinase domain in these structures 
still lacks some of the features of the active kinase domain conformation; in 
particular the DFG-F540 motif in these structures is not optimally positioned in-
spite of it being in ‘DFG-in’ state. 
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Fig. 8. (a) Initial velocity measurements of isolated Btk kinase domain using 
the poly (4:1 Glu, Tyr) peptide substrate. The activity of the isolated Btk kinase 
domain is equivalent to no enzyme.  
(b) Western blot to probe the activity level of Btk linker-kinase and Btk 
(W395A) linker-kinase domain using antibody recognizing activation loop Y551 
phosphorylation level (Anti-pY551) and antibody recognizing phosphorylation 
status of substrate PLCγ1 (Anti- PLCγ1 pY783). Anti-His compares the amount 
of Btk linker-kinase and Btk (W395A) linker-kinase used in western blot 
assays. (c) Crystal structure of Btk linker-kinase domain (PDB ID: 3K54). The 
SH2-kinase linker in the crystal structure is colored in salmon and W395 side-
chain is shown as sticks. Btk kinase domain is shown in grey. 
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Therefore, the trapped conformation of the Tec family kinase domains 
in crystal structures combined with biochemical studies indicate that the kinase 
domain of Tec family favors the inactive conformation. It is thus hypothesized 
that there must exist a number of sequence/structural motifs outside of the 
conserved features, which maintain the Tec family kinase domains in the 
inactive conformation. These sequence/structural differences must be 
contributing to the differences in regulation of the kinase domain in the Tec 
family from other protein tyrosine kinase families. While kinase domains from 
the Src family readily adopt the active conformation, the Tec family kinase 
domains do not.  The motivation of our work is thus to identify the unique 
regulatory features in the Tec kinase family and understand their mechanism, 
which could lead to the identification of selective inhibitors for Tec family 
kinases in future. 
 
Thesis organization 
This thesis includes five chapters. Chapter 1 gives a general 
introduction and the necessary information on Bruton’s Tyrosine kinase (Btk). 
It emphasizes the sequence and structural features of the kinase domain, 
which function to regulate Btk kinase domain activity. Chapter 2, which has 
been published in the Journal of Molecular Biology, describes the discovery of 
an activating mutation in the Btk kinase domain and describes how the Btk 
kinase domain maintains the inactive state. Chapter 3, published in PLoS 
Computational Biology, describes the mechanism by which an amino acid 
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outside of the Btk kinase domain (in the SH2-linker region), functions to 
stabilize the active conformation of the Btk kinase domain. Chapter 4, is an 
ongoing project, in which we have described the discovery of a specific 
mutation in the Btk kinase domain that rescues Btk kinase activity in the 
presence of an inactivating XLA causing mutation. Chapter 5 summarizes the 
conclusions we have derived from our findings and the future direction of these 
projects. 
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Abstract 
Despite high level of homology among non-receptor tyrosine kinases, 
different kinase families employ a diverse array of regulatory mechanisms. 
For example, the catalytic kinase domains of the Tec family kinases are 
inactive without assembly of the adjacent regulatory domains, whereas the 
Src kinase domains are autoinhibited by the assembly of similar adjacent 
regulatory domains. Using molecular dynamics simulations, biochemical 
assays, and biophysical approaches, we have uncovered an isoleucine 
residue in the kinase domain of the Tec family member Btk that, when 
mutated to the closely related leucine, leads to a shift in the conformational 
equilibrium of the kinase domain toward the active state. The single amino 
acid mutation results in measureable catalytic activity for the Btk kinase 
domain in the absence of the regulatory domains. We suggest that this 
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isoleucine side chain in the Tec family kinases acts as a “wedge” that restricts 
the conformational space available to key regions in the kinase domain, 
preventing activation until the kinase domain associates with its regulatory 
subunits and overcomes the energetic barrier to activation imposed by the 
isoleucine side chain. 
 
Introduction 
Protein kinases transfer the γ-phosphate of ATP to the side chain of a 
substrate molecule, serving as key mediators of cellular signaling pathways. 
Given the importance of this chemical modification in driving cellular 
responses to stimuli, kinase catalytic activity is tightly controlled. There are 
well-defined, conserved structural elements that must be appropriately 
assembled for catalysis, serving as hallmarks of an active kinase (Fig. 1a): 
the Lys/Glu salt bridge, the regulatory spine (R-spine)1,2,3,4, the αC helix, and 
the DFG motif5. Phosphorylation of one or more hydroxyl-containing side 
chains in the activation loop (A-loop) triggers assembly of the active kinase 
conformation (Fig.1a). Specifically, the activation loop phosphotyrosine 
attracts a conserved Arg in the same loop, pulling it away from an 
electrostatic interaction with a conserved Glu on the αC helix. This transition 
releases the αC helix so that it switches from an “αC-out” to an “αC-in” 
conformation, leading to the short distance (< 4 Å) between the side chains of 
the conserved Glu and a conserved Lys, forming a new electrostatic 
interaction characteristic of the active kinase6. This electrostatic switch is 
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accompanied by assembly of the regulatory spine residues and a 
conformational shift in the DFG motif forming a hydrogen bond between the 
carboxylate side chain of the aspartate (Oδ1) and the backbone amide (NH) of 
the glycine. 
 
Despite the fact that this set of structural features is present in all 
active kinases, it is clear that different kinases follow different regulatory rules. 
Striking examples are the Tec7,8,9,10 and Src family tyrosine kinases11,12; these 
kinase families are closely related evolutionarily but employ opposing 
regulatory schemes. Tec kinase domains, even when phosphorylated on the 
activation loop, are inactive, relying on direct association with regulatory 
regions outside of the kinase domain to achieve activation13,14,15,16. In 
contrast, phosphorylated Src family kinase domains are fully active by 
themselves17,18 and are inhibited by association with their regulatory 
domains19,20. This fundamental difference suggests that there are unique 
structural motifs within the Tec family that “hold” these kinase domains in the 
inactive conformation until proper assembly with the adjacent regulatory 
domains. 
 
Here we use a combination of computational methods, biochemical 
assays, and biophysical methods to identify the molecular determinants that 
are responsible for the “inactive by default” status of the Tec family kinases. 
To identify the regulatory features within the Tec and Src family kinase 
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domains that are responsible for the observed differences in catalytic 
efficiency, we focus on two specific kinases, Btk (one of five Tec family 
kinases) and Lck (one of nine Src family kinases); these specific kinases were 
chosen based on availability of high-resolution crystal structures of each 
kinase domain in the active conformation. Our findings point to an isoleucine 
residue conserved among the Tec family kinases, which acts as a “wedge” 
restricting the conformational space available to key regulatory elements of 
the kinase domain. Removing the wedge by mutation of isoleucine to leucine, 
the corresponding residue in the Src kinases, results in increased 
conformational sampling and leads to partial activation of the Tec family 
kinase domain in the absence of the otherwise necessary regulatory region. 
Elucidating the molecular details that account for the conformational 
preferences and respective activities of the Tec and Src family kinase 
domains is important for fully understanding the regulatory mechanisms that 
govern signaling through these kinases. 
 
Results 
Molecular dynamics simulations reveal differences in the conformational 
preferences of Lck and Btk kinase domains 
To explore the differences in the Lck and Btk kinase domains that 
differentially drive the assembly of the active catalytic core, we initialized all-
atom molecular dynamics (MD) simulations starting from the active 
conformations of each kinase domain. PDB ID 3LCK was used as the starting 
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structure for active Lck kinase domain and PDB ID 3K54 was used as the 
starting structure for active Btk kinase domain. We performed 100-ns 
equilibrium simulations in the normal pressure temperature ensemble, with 
three replicates for the Btk structure and two replicates for Lck. Throughout 
the simulations, RMSD was monitored from the starting structure for the 
hallmarks of the active catalytic core, as well as distances between specific 
residues involved in electrostatic interactions in and around the active site 
(Fig. 1b and c and Fig. S1a). The Lck kinase domain retains its active 
conformation throughout the entire 100 ns in both replicates (Fig. 1b). This is 
consistent with a recent MD study showing that the Src kinase domain retains 
the active, assembled catalytic core during a simulation of 10 µs21. In 
contrast, the Btk kinase domain deviates from its starting active structure 
early in the simulation (Fig. 1c). Structural changes in Btk are localized within 
the N-lobe of the kinase; the Btk αC helix moves away from the N-lobe, 
breaking the K430/E445 salt bridge and disassembling the regulatory spine 
(Fig. 1c). During the simulations, Btk samples inactive conformations 
observed in numerous Tec family kinase domain crystal structures in which 
the αC helix adopts the inactive αC-out position but the A-loop is in the active 
“open” position. Additionally, the observed outward movement of the Btk αC 
helix led to formation of the R544/E445 salt bridge in one replicate, a 
structural feature that is observed in many inactive kinase domain structures 
(Fig. S1b). 
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Given the differences in the simulations of Btk and Lck, we set out to 
identify molecular features that lead to the spontaneous conformational shift 
away from the active Btk kinase domain structure. We focused on the αC 
helix since the most pronounced changes occur in this region of the structure 
during the course of the simulation. Assessing the relative structural stability 
conferred by local interactions within protein kinases has proven useful in 
determining the molecular basis of cancer causing mutations that likely alter 
the conformational preferences of a kinase domain22. The hypothesis is that 
specific side chains that cannot form optimal contacts within the surrounding 
structure will be a driving force for conformational changes that allow for 
optimal interactions. Drawing an analogy to that work, we performed 
mutational frustration analysis (see Materials and Methods)23,24,25 at 0, 10, 
and 100 ns time points from the Btk simulation. A number of frustrated 
contacts are evident for residues on the αC helix early in the simulation and 
these non-optimal contacts are resolved as the αC helix moves to the αC-out 
conformation (Fig. S2a). Four αC helix residues, E439, E441, F442, and 
E445, participate in the majority of the frustrated contacts at early time points 
in the simulations (Fig. S2b), indicating that these sites are likely regions of 
local instability in the structure of the active Btk kinase domain. Since these 
frustrated αC helix residues all face the N-lobe, we reasoned that mutation of 
these amino acids might relieve the non-optimal contacts and stabilize the 
active, αC-in conformation of the Btk kinase domain. E439 and E441 are 
unique to the Tec family kinases (not conserved in Src kinases), and thus, 
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these Btk residues are targets for mutagenesis to the corresponding residues 
in Lck (E439P and E441A). 
 
The other two residues on the αC helix identified by frustration 
analysis, F442 and E445, are completely conserved throughout the Tec and 
Src family kinases, and thus, direct mutation of these residues was not 
pursued. However, the fact that these residues are at the hub of a locally 
frustrated region within the active Btk kinase domain structure prompted us to 
examine amino acids interacting with F442 and E445, using a contact radius 
of 6 Å (Fig. S2c). Excluding residues on the αC helix itself, we find that F442 
and E445 are within 6 Å of the side chains of eight different residues in the 
Btk kinase domain:K430, I432, V463, T465, I470, I472, D539, and F540 (Fig. 
S2c). Seven of these amino acids (underlined in the list above) are either 
conserved across both the Tec and Src family kinases or present in certain 
members of both families. Btk I432 is unique as it is conserved among the 
Tec kinases but not present in any of the Src family kinases. In the Src 
kinases, this residue corresponds to either leucine or methionine. Thus, in 
addition to the Btk E439P and E441A mutations, mutation of Btk I432 to a 
leucine (present in Lck) is also a candidate for further characterization by in 
vitro kinase assays. 
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Mutation of isoleucine 432 to leucine relieves the inactive by default status of 
the Btk kinase domain 
Based on analysis of the MD simulations, three mutations (I432L, 
E439P, and E441A) were introduced together and separately into the His-
tagged Btk kinase domain and each protein was expressed and purified. Btk 
kinase activity was first assessed by Western blot to measure 
autophosphorylation using a phosphotyrosine specific antibody for the 
phosphorylation site (Y551) on the Btk activation loop (Fig. 2a). Activation 
loop phosphorylation is commonly used as a qualitative indicator of kinase 
activity26,27. Western blot analysis indicates that the triple mutant (Btk 
IEE/LPA) is more active than wild-type Btk, consistent with analysis of the Btk 
simulation data suggesting that I432, E439, and E441 contribute to the 
destabilization of the active Btk conformation. For the separate mutations, 
I432L activates Btk whereas the E439P and E441A do not (Fig. 2a). Initial 
velocity measurements for phosphorylation of the poly (4:1 Glu,Tyr) peptide 
also show that Btk I432L is catalytically more active than wild-type Btk for this 
generic substrate (Fig. 2b). The 5-fold activity increase (Vi/[Enzyme] = ~ 0.5 
for Btk I432L and Vi/[Enzyme] = ~ 0.1 for isolated Btk kinase domain) can be 
compared with that of full-length Btk to assess the extent of activation realized 
by the I432L mutation. The previously published initial velocity data for full-
length Btk, Vi/[Enzyme] = 2 min− 1(14), suggests that the I432L mutation in the 
Btk kinase domain activates the isolated Btk kinase domain to 25% of that of 
the full-length enzyme. It should be noted here that the previously 
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characterized full-length Btk protein was expressed and purified from insect 
cells rather than the bacterial expression system used here for the kinase 
domain fragments. 
 
To further characterize the I432L mutation, we made use of a 
previously published mutant Btk kinase domain, Btk Y617P28. The Y617P 
mutation is located in the C-lobe of the kinase domain and results in higher 
yield from bacteria than the wild-type Btk kinase domain, facilitating more 
detailed enzymology and biophysical characterization. We have previously 
noted that the Y617P mutation enhances the basal activity of the Btk kinase 
domain by an unknown mechanism, and thus, we first wished to assess 
whether the I432L mutation causes the same activation in this background 
compared to wild-type Btk kinase domain. Using autophosphorylation of Y551 
as a qualitative indicator of activity, we find that the Btk Y617P/I432L kinase 
domain retains the activity enhancement over the Btk Y617P kinase domain 
observed for the wild-type kinase domain and I432L single mutant (Fig. 2c). 
We therefore proceeded with quantitative assays to 
determineKM and kcat values for the Btk Y617P kinase domain with and 
without the I432L mutation. Peptide substrate curves were generated using 
peptide B (aminohexanoyl biotin-EQEDEPEGIYGVLF-NH2) and the data 
were fit to determine KM and kcat values for the Btk kinase domain and the 
I432L mutant kinase domain (Fig. 2d). The Btk Y617P/I432L mutant kinase 
domain exhibits a kcat value of 12.2 ± 1.3 min− 1, seven times faster 
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thankcat = 1.7 ± 0.2 min− 1 for the Btk kinase domain carrying the wild-type 
isoleucine at position 432. The KM value for the Btk I432L mutant kinase 
domain does not change significantly from that of the Btk kinase domain 
[KM(Btk Y617P) = 179 ± 40 µM; KM(Btk Y617P/I432L) = 275 ± 57 µM]. To 
ensure that the observed activity differences are not arising due to stability 
differences between Btk Y617P and Btk Y617P/I432L, we measured thermal 
denaturation curves for both proteins and find that the more active Btk 
Y617P/I432L kinase domain is in fact slightly less stable than Btk Y617P 
kinase domain (Fig. S3). The Btk kinase domain Y617P/I432L mutant exhibits 
a Tm = 43 °C compared toTm = 44.5 °C for the Btk kinase domain Y617P. 
Thus, results of qualitative Western blot analysis, initial velocity 
measurements, and peptide phosphorylation kinetics all show that 
substitution of the isoleucine at position 432 with leucine increases the 
catalytic activity of the isolated Btk kinase domain. 
 
We next carried out 50-ns simulations for Btk I432L, using the same 
starting conformation (3K54) and parameters as the simulations in Fig. 1 (Fig. 
3a and Fig. S2d). Throughout the simulation, the Btk I432L mutant retains the 
hallmarks of an active kinase (Fig. 3a) to a greater extent than the 
corresponding simulation of the wild-type Btk kinase domain (Fig. 1c). At the 
end of the simulation, the leucine side chain introduced at position 432 in Btk 
has rotated around the Cα–Cβ bond to adopt the trans chi1 rotamer 
conformation creating space for the F442 side chain on the C helix (Fig. 3b). 
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The resulting αC-in conformation appears stabilized by favorable contacts 
between the F442 side chain and the side chains of L432 and I472; the latter 
residue is conserved in both Tec and Src kinases. The final structure 
surrounding F442 in the simulation of the Btk I432L kinase domain is very 
similar to the structure of the Lck kinase domain throughout its entire 
simulation (Fig. 3c). 
 
This analysis of the Btk I432L mutant prompted closer inspection of the 
I432 rotamer population in the wild-type Btk crystal structure and simulation 
data. The precise position of the isoleucine side-chain atoms in the Btk kinase 
domain structure is uncertain due to poor side-chain electron density. The 
reported B-factors for this region of the structures are high, consistent with 
flexibility or uncertainty in this region. We therefore used the simulation data 
to monitor rotamer occupancies over time for the I432 side chain. Plotting the 
Btk I432 chi1 angle as a function of simulation time reveals multiple rotameric 
states with a preference for the gauche(+) and gauche(−) rotamers (chi1 of 
± 60°) and only a transient occupancy of the trans rotamer (chi1 of ± 180°) 
(Fig. 4a–c). The I432 gauche(+) chi1 angle results in the delta methyl group 
(Cδ) of I432 pointing directly toward F442 on the αC helix providing a steric 
block to the αC-in conformation that is required for the active kinase (Fig. 4b). 
The gauche(−) chi1 angle for I432 also places the sterically bulky isoleucine 
side chain in a position that blocks F442 (Fig. 4c). 
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The same chi1 analysis for the corresponding leucine for both Lck 
(L275) and the Btk I432L mutant suggests that, in these cases, the non-β-
branched leucine side chain predominantly occupies the trans rotamer 
(Fig. 4d and e) as already observed at the end point of the Btk I432L 
simulation (Fig. 3b). The trans leucine rotamer does not sterically block the 
phenylalanine side chain on the αC helix resulting in an increase in the 
conformational space available to the αC helix of Lck and Btk I432L (Fig. 4f). 
Moreover, L275 in the Lck kinase domain structure has low B-factors for the 
side-chain atoms indicating that the trans chi1 angle is a stable conformation 
in the crystal. 
 
The simulation data suggest that the steric effect of the I432 side chain 
on the local structure of the Btk kinase domain N-lobe, in particular, the 
phenylalanine on the αC helix, is distinct from that of the corresponding 
leucine in the Src family kinases. The rotameric preferences of the β-
branched I432 side chain seem to create a wedge that limits the 
conformational space available to the Btk αC helix in the isolated Btk kinase 
domain (Fig. 5a, left). Mutation of Btk I432 to the non-β-branched leucine 
opens the hydrophobic surface formed by L432 and I472 (see Fig. 3b) to 
accommodate the side chain of F442. In a similar manner, we suggest that 
the conformational preference of the native isoleucine side chain in wild-type 
Btk could shift to the trans chi 1 rotamer upon activation by the associated 
regulatory domains of Btk, creating space for F442 and allowing the αC helix 
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to more readily sample the αC-in conformation of the active kinase domain 
(Fig. 5a, right). 
 
The proposed model predicts that, in full-length Btk, the non-catalytic 
regulatory region provides sufficient stabilization energy to overcome the 
intrinsic conformational preference of the isolated kinase domain for the 
inactive state, presumably shifting the I432 chi1 rotamer population toward 
the trans conformation resulting in greater sampling of the active 
conformation. To test this hypothesis, we introduced the I432L mutation into 
full-length Btk and compared the activity of this mutant with the non-mutated 
full-length Btk kinase. The activities of full-length Btk and full-length Btk I432L 
are indistinguishable by Western blot analysis probing activation loop (pY551) 
phosphorylation levels (Fig. 5b). In this experiment, we probed activation loop 
phosphorylation levels before and after incubation with ATP to show that both 
proteins, when purified, start at the same (low) level of phosphorylation on 
Y551. The corresponding experiment for the isolated Btk kinase domain 
demonstrates the activating effect of I432L (Fig. 5c) after incubation with ATP 
as already shown in Fig. 2. 
 
The I432L mutation alters the conformational equilibrium of the Btk kinase 
domain 
To experimentally test the hypothesis that the Btk I432L mutant is 
more active than wild-type Btk kinase domain due to differences in the 
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conformational space available to the αC helix, we turned to NMR 
spectroscopy to measure the dynamics of residues in this region of the Btk 
kinase domain. The resonance frequency of every hydrogen (1H) that is 
directly attached to a nitrogen (15N) is measured using a TROSY 
(transverse relaxationoptimized spectroscopy) version of the HSQC 
(heteronuclear single quantumcoherence) spectrum29. The resulting data 
provide a direct measure of the chemical environment and dynamical 
properties of each amide NH group in the protein. Comparison of the 1H-15N 
TROSY HSQC spectrum of uniformly 15N-labeled Btk kinase domain with that 
of 15N-labeled Btk I432L reveals linewidth differences for a subset of peaks 
indicative of dynamic differences in specific regions of the two proteins 
(Fig. 6a and b). Overall, NMR linewidths are broader for the Btk I432L mutant 
than for the wild-type Btk, suggesting that the activated mutant is more 
dynamic. Complete backbone resonance assignments for the Btk kinase 
domain are not available, and thus, we have pursued selective isotopic 
labeling to obtain chemical shift assignments for the phenylalanine backbone 
amide resonances in the Btk kinase domain27,28. 
 
In the present work, the amide resonance corresponding to F442 on 
the αC helix could not be unequivocally assigned. Having previously assigned 
the backbone amide of F54027, we examined its resonance in 1H-15N TROSY 
HSQC spectra of the Btk wild-type and I432L mutant kinase domains. The 
location of F540 within the conserved DFG motif places it close in space to 
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the αC helix (Fig. 1a) where it is likely to report on dynamic changes that 
result from substitution of I432 with leucine. Indeed, a peak corresponding to 
F540 is present in the 1H-15N TROSY HSQC of wild-type Btk, but it is absent 
in the spectrum of Btk I432L due to line broadening and/or a significant 
resonance frequency change (Fig. 6a and b). The absence of new peaks in 
the spectrum of Btk I432L kinase domain that are not present in the wild-type 
data favors line broadening to explain the disappearance of the F540 amide 
resonance. The significant change in the F540 resonance combined with 
observation of overall line broadening in the spectrum of Btk I432L is 
consistent with an increase in conformational exchange on the microsecond 
or faster timescale30 in the more active Btk I432L mutant. 
 
The spectral changes in the F540 amide resonance that are observed 
upon mutation of I432 to leucine prompted us to compare the DFG motif in 
simulations of wild-type Btk with that of the Btk I432L mutant. The DFG motif 
in all available crystal structures of the Btk kinase domain adopts a 
conformation that is not optimal for an active kinase. More specifically, the Btk 
3K54 crystal structure has a DFG motif that is similar to the “DFG-in” 
conformation, but the carboxylate side chain of D539 (Oδ1) does not form a 
hydrogen bond to the backbone amide (NH) of G541 (Fig. 6c, left). Moreover, 
in simulations of wild-type Btk kinase domain, the distance between Oδ1 of 
D539 and the backbone amide nitrogen (N) of G541 varies between 6 and 
8 Å, suggesting that the hydrogen bond is never significantly populated 
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(Fig. 6c, right). In contrast, during the simulation of the Btk I432L mutant, the 
DFG motif adopts a conformation in which the aspartate Oδ1 is < 3.5 Å from 
the glycine backbone amide (N), consistent with formation of a hydrogen 
bond (Fig. 6d, right). In one of the two replicates, the hydrogen bond is 
maintained for a significant time during the simulation while the short distance 
between Oδ1 and N is only transiently populated in the other replicate. A 
snapshot of the Btk I432L kinase domain during the simulation shows 
formation of the Oδ1/NH hydrogen bond within the DFG motif (Fig. 6d, left). 
The DFG conformation observed in the Btk I432L simulation is 
indistinguishable from that in the active structure of Lck. Thus, NMR data 
combined with MD simulations suggest that mutation of I432 to leucine within 
Btk results in conformational sampling of the optimal DFG-in structure 
associated with the active state of protein kinases. 
 
To further probe the dynamic characteristics of the Btk I432L mutant, 
we compared the solution behavior of Btk kinase domain with the Btk I432L 
kinase domain mutant by hydrogen/deuterium exchange mass spectrometry 
(HDXMS). HDXMS allows detection of backbone amide hydrogens for each 
amino acid in the protein (except proline) so that a direct comparison of the 
solvent accessibility/hydrogen bonding of the amide N-H can be made for 
wild-type Btk and the Btk I432L mutant. Comparison of the hydrogen 
exchange behavior for Btk I432L versus wild-type Btk showed measurable 
changes in deuterium incorporation in the kinase domain for the I432L mutant 
	   40	  
(Fig. 7a and Fig. S4). Most of the changes in deuterium exchange are 
localized in the N-lobe of the kinase, with the C-lobe remaining relatively 
unperturbed. The largest differences in deuterium uptake are observed in 
peptides that cover the β2 strand, the β2-β3 loop, and the N-terminal end of 
the activation loop in the Btk I432L mutant compared to wild-type Btk (Fig. 7a 
and b). For these regions of secondary structure, the Btk I432L mutant 
exchanges more readily than wild-type Btk, suggesting that the mutant protein 
samples more open conformations than wild-type Btk. The Btk I432L mutant 
also shows small differences in deuterium uptake for part of the β3 strand, β4 
strand, β4-β5 loop, β5 strand, β6 strand, β6-β7 loop, β7 strand (including the 
DFG motif), the catalytic loop, and the C-terminal end of the activation 
segment (Fig. 7b–d). In these peptide regions as well, Btk I432L showed 
increased deuterium incorporation although more moderate when compared 
to wild-type Btk. It is also interesting to note that hydrogen/deuterium 
exchange does not differ between the two proteins for the αC helix itself, 
suggesting that amide hydrogen accessibility within this region of secondary 
structure is not affected by the mutation. Thus, to the extent that the αC helix 
samples greater conformational space in the Btk I432L mutant, it does so in a 
concerted fashion without changes to the helical structure. 
 
Discussion  
Leucine and isoleucine are structural isomers that are often considered 
interchangeable due to their related hydrophobic side chains31,32. At the same 
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time, it is appreciated that the β-branched isoleucine side chain introduces 
conformational restrictions that can either stabilize or destabilize the 
polypeptide chain depending upon context33. For Btk and the Tec family 
kinases, MD simulation data suggest that specific chi 1 rotamers of the 
isoleucine at position 432 in the kinase domain sterically maintains the 
inactive kinase domain conformation (αC helix out) in the absence of the Btk 
regulatory domains. Mutation of the I432 to the non-β-branched leucine likely 
shifts the rotamer preference at this position, leading to changes in protein 
motions and an increase in activity for the isolated Btk kinase domain. Indeed, 
the I432L mutation selectively affects kcat and not KM, consistent with the 
notion that this mutation allows the Btk kinase domain to more frequently 
sample the active state. 
 
In the full-length Btk kinase, assembly of the non-catalytic regulatory 
domains onto the Btk kinase domain shifts the conformational preference of 
the kinase domain to the active state, superseding the effects of the leucine 
substitution that are evident in the isolated kinase domain. Presumably, in the 
controlled signaling pathways of Btk, negative regulatory signals would 
promote release of the Btk kinase domain from interactions with the 
regulatory domains, leading to a conformational shift in the kinase domain 
toward the inactive state. The shift from active to inactive state is driven in 
part by the conformational preferences of the I432 side chain within the 
released Btk kinase domain. 
	   42	  
Mutations that favor the αC-in conformation of any kinase could result 
in hyperactivation. Mutation of F457 (corresponds to F442 in Btk) to leucine in 
the Tec family kinase Bmx is reported in the COSMIC 
(Catalogue of Somatic Mutations in Cancer) database34,35.The phenylalanine-
to-leucine mutation changes the face of the αC helix in Bmx and the less 
sterically demanding leucine side chain may pack more favorably with the 
isoleucine in Bmx (I447), leading to increased catalytic activity of the Bmx 
F457L kinase domain. Along these lines, it is also interesting to note that a 
leucine-to-phenylalanine mutation at the position corresponding to Btk I432 
within the B-Raf kinase (L485F) is reported in the COSMIC database. Given 
the conserved phenylalanine on the αC helix (B-Raf F498 corresponding to 
F442 in Btk), it is tempting to speculate that a phenylalanine in place of 
leucine on the β3 strand of B-Raf might form favorable pi stacking interactions 
with F498 on the αC helix stabilizing the active αC-in conformation. These 
reports collectively suggest that side-chain packing in the region defined in 
this study can have significant effects on kinase catalytic activity. These 
effects may not be limited to kinases, as activity changes due to mutation of 
isoleucine to leucine have been characterized for several non-kinase 
systems36,37,38. In one example, the human prolactin receptor is activated by 
mutation of an isoleucine to leucine resulting in dynamical changes and 
stabilization of the active state39. 
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Both NMR spectroscopy and HDXMS support a model in which the Btk 
kinase domain experiences greater dynamic flexibility in the active state 
compared to the inactive state. The increase in deuterium incorporation 
suggests that the Btk I432L protein samples more open conformations than 
the wild-type Btk kinase domain. NMR analysis of the phenylalanine in the 
DFG motif of Btk (F540) reveals differences in the relaxation properties of this 
residue in the context of Btk wild type versus Btk I432L. Given the proximity of 
the DFG motif to the αC helix, the observed increase in exchange broadening 
for the backbone amide of F540 in Btk I432L may reflect the nearby αC helix 
sampling greater conformational space that includes the αC-in conformation 
associated with the kinase active state. In view of the well-characterized 
conformational shift of the DFG motif between active and inactive kinase 
structures3, it is tempting to speculate that the slower conformational 
fluctuations on the microsecond timescale within Btk I432L evident in the 
NMR data may reflect exchange between DFG conformations. Along these 
lines, it is interesting to note that the optimal DFG-in state is not observed in 
the crystal structures of Btk, perhaps another consequence of destabilization 
of the active state by I432. Indeed, the importance of the interplay among the 
DFG motif, the regulatory spine (which includes the DFG phenylalanine), and 
the stability of the active kinase has been recently addressed in related work 
on PKA40, and together, these findings emphasize the importance of the DFG 
phenylalanine in the assembled regulatory spine. Finally, the microsecond 
timescale motions detected for the DFG motif in the more active form of Btk 
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(I432L) may also contribute directly to catalysis as has been suggested for 
other systems41,42,43. 
 
The increasing power of MD simulations coupled with experiment 
offers a promising approach to elucidate the molecular determinants that 
control enzyme activity and regulation21,44. Our combined use of computation 
and experiment suggests that a single, conserved isoleucine residue is at 
least partly responsible for keeping Tec family kinase domains inactive until 
upstream signaling events trigger association between the non-catalytic 
regulatory region and kinase domain14. Future work will aim to elucidate yet 
unidentified sequence and/or structural features that cooperate with the 
isoleucine 432 to drive the conformational equilibrium of the Tec family kinase 
domains toward the inactive state in the absence of the non-catalytic 
regulatory domains. A full mechanistic understanding of how the 
conformational equilibrium of the Tec kinase domains is controlled may lead 
to new opportunities in kinase inhibitor development. Additionally, the 
structural features exploited by the Btk kinase domain to favor the inactive 
conformation could provide clues and/or inspiration in drug discovery efforts 
aimed at inhibiting kinase domains that, unlike Btk, are active by default. 
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Materials and Methods 
Structure preparation for simulations 
Initial coordinates were obtained from the Protein Data Bank (PDB): 
3K54 for active Btk kinase domain and 3LCK for active Lck kinase domain. 
The starting structures consisted of the single kinase domains in the apo state 
(absent ATP or inhibitor), corresponding to amino acids 396–659 for Btk and 
amino acids 239–501 for Lck. Both 3K54 and 3LCK contain a linker region N-
terminal to the kinase domain that has been removed in order to monitor the 
effects of the isolated kinase domains and ensure identical domain 
boundaries for direct comparison of Btk to Lck. Regions missing from the 
electron density maps were modeled using MODELLER45 and related active 
kinase domain structures as templates (see details in Supplemental Data). In 
all of the simulation systems, the kinase domains were phosphorylated, using 
the phosphotyrosine patch TP2, at the Tyr residue of the activation loop 
(Y551-Btk and Y394-Lck) to reflect the physiological state of the active 
kinase. The 3LCK crystal structure is phosphorylated at this position and the 
3K54 crystal structure contains the Y551E phosphomimetic mutation at this 
position that was changed in silico to pY551. The I432L mutant structure was 
generated using MODELLER45 and SCWRL 446. 
 
Simulation setup 
All-atom MD simulations were performed using the CHARMM2747force 
field and TIP3P explicit water model in the NAMD 2.8 program48. The 
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simulation systems were solvated in a periodic water box with 15 Å buffering 
distance between protein surface and the box. Na+ and Cl− ions were added 
to neutralize the charge of the system, with a final molar concentration of 
approximately 150 mM. Systems were equilibrated and simulated in the 
normal pressure temperature ensemble at 310 K and 1 atm, using particle-
mesh Ewald for long-range electrostatics. The cutoff used for the van der 
Waals and short-range electrostatics calculations was 12 Å and covalent 
hydrogens were kept rigid using the ShakeH algorithm. The simulation 
systems consisted of ~ 51,000 atoms. The time step used was 2 fs. 
Simulation systems were first minimized (20 ps) and equilibrated (50 ps) 
holding the protein rigid, allowing water molecules and Na+ and Cl− ions to 
move. The modeled loops were then subjected to a short minimization to 
remove steric clashes. Next, the entire system was minimized, gradually 
releasing harmonic constraints on all protein heavy atoms. The temperature 
of the system was then raised from 200 K to 310 K (5 K increments over 
90 ps) with harmonic constraints on all protein heavy atoms. Subsequently, 
the harmonic constraints were gradually released and the system was 
equilibrated for a total time of approximately 1 ns before starting production 
runs for analysis. 
 
Analysis of simulation trajectories 
Analysis of MD trajectories was carried out using VMD49 and MATLAB 
(The Mathworks, Inc.). For RMSD calculations, superposition was based on 
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the backbone atoms of the C-lobe, which in all simulations showed minimal 
movement, using the minimized starting structure for that simulation as the 
reference. Salt bridge distances were measured in VMD using the distance 
between the center of mass of the oxygens in the negatively charged side 
chain and the center of mass of the nitrogen in the positively charged side 
chain. Snapshots at 10-ns intervals were submitted to the Frustratometer 
server25,50. Mutational frustration scores, both pairwise and single-residue, 
were extracted from this analysis and used to identify frustrated residues. A 
Frustration Index (or z-score) ≥ 0.78 is minimally frustrated and < – 1.0 is 
highly frustrated. Figures were generated using PyMOL51. 
 
Protein expression, purification, and in vitro kinase assays 
Btk mutants were generated by site-directed mutagenesis 
(QuikChange II kit; Stratagene). All constructs were confirmed by sequencing 
at the Iowa State University DNA Synthesis and Sequencing Facility. His6-
tagged Btk (residues 369–659) kinase domains (wild type and mutants used 
for Fig. 2a and b) are expressed in Arctic Express BL21(DE3) cells 
(Stratagene). Btk constructs (both kinase domain fragment and full length) 
containing the previously described Y617P28 mutation are expressed in 
BL21(DE3) cells. Proteins used for enzymatic analysis and NMR 
spectroscopy are purified as previously described52. Full-length Btk Y617P 
and Btk Y617P/I432L are co-expressed with YopH to improve expression 
yield. Proteins used for HDXMS were further purified on a Hiload 75 (GE 
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Healthcare) gel-filtration column, concentrated to 80 µM, snap frozen in 
100 µl aliquots, and stored at − 80 °C. 
 
Kinase assays were performed as in Joseph et al.15 using either wild-
type Btk kinase domain and the corresponding Btk mutants (I432L, E439P, 
E441A, and IEE/LPA) or Btk kinase domain Y617P and the corresponding Btk 
Y617/I432L mutant as indicated. Kinase reactions were carried out using 300 
nM enzyme and analyzed by Western blot and activity detected with anti-Btk 
pY551 antibody (BD Biosciences). Kinase assays involving the poly (4:1 
Glu,Tyr) peptide substrate were carried out at room temperature by 
incubating the enzyme in a reaction buffer of 50 mM Hepes (pH 7.0), 10 mM 
MgCl2, 1 mM dithiothreitol (DTT), 1 mg/ml bovine serum albumin, 1 mM 
Pefabloc, 5 mCi [32P]ATP, 5 mg/ml poly (4:1 Glu,Tyr) peptide (Sigma), and 
200 µM ATP. The peptide substrate was captured on a P-81 membrane 
(Whatman), washed thrice with 0.1% phosphoric acid, washed once with 70% 
ethanol, dried, and counted by scintillation counting. Full-length Btk enzymes 
and Btk kinase domains used in the kinase assays shown in Fig. 5 are co-
expressed with YopH to eliminate activation loop phosphorylation prior to 
initiating the kinase assay53. As a result, kinase assays using proteins 
produced in this way include the phosphatase inhibitor sodium orthovanadate 
(1 mM). Kinetic parameters for Btk kinase domain Y617P and Btk kinase 
domain Y617P/I432L are derived using radioactive assays as follows: 1 µM 
Btk kinase domain Y617P or Y617PI432L mutant was incubated with peptide 
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B substrate (aminohexanoyl biotin-EQEDEPEGIYGVLF-NH2, a previously 
identified Tec family kinase substrate16). Peptide concentrations ranged from 
0 to 550 µM in the reaction buffer {50 mM Hepes, pH 7.0, 10 mM MgCl2, 
1 mM DTT, 1 mg/ml bovine serum albumin, 1 mM Pefabloc, 200 µM ATP, and 
5 µCi of [32P]ATP (Perkin Elmer)} at room temperature. At 10-min and 20-min 
reaction times, 10 µl of the reaction mixture was removed and mixed with 5 µl 
of 8 M guanidine hydrochloride to terminate the reaction. We then spotted 
10 µl of this reaction mixture onto the biotin capture membrane (Promega) 
and washed it, and we quantified the radioactivity incorporated on the peptide 
B substrate by scintillation counting. Each assay was performed in duplicate. 
The initial velocity of phosphorylation was then derived and KM and kcat values 
were obtained from fitting the data to the Michaelis–Menten equation using 
GraFit. 
 
NMR spectroscopy 
Uniformly 15N-labeled isolated kinase domains of Btk wild type or Btk 
I432L (both containing the Y617P mutation) were produced in Escherichia 
coli BL21(DE3) cells, as described previously28. 15N-Phenylalanine-labeled 
samples were produced by growing the E. coli BL21(DE3) cells in modified 
minimal media as previously described28. The purified proteins were 
concentrated and dialyzed into buffer consisting of 50 mM N,N-bis(2-
hydroxyethyl)glycine (pH 8.0), 75 mM NaCl, 2 mM DTT, 5% glycerol, and 
0.02% NaN3. All NMR spectra were collected at 298 K on a Bruker AVII 700 
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spectrometer equipped with a 5-mm HCN z-gradient cryoprobe operating at 
a 1H frequency of 700.13 MHz. All data were analyzed with NMRViewJ 
software54. 
 
Hydrogen/deuterium exchange mass spectrometry 
Btk kinase domain samples for HDXMS contain a Y551F mutation on 
the kinase activation loop to prevent complications in the analysis due to 
differential phosphorylation. Deuterium labeling was initiated with an 18-fold 
dilution of an aliquot (80 pmol) of Btk wild type and Btk I432L (both containing 
Y617P) into a buffer containing 99.9% D2O, 20 mM Tris, 150 mM NaCl, and 
10% glycerol, pD 8.01. The labeling reaction was quenched with the addition 
of an equal volume of quench buffer [150 mM potassium phosphate 
(pH 2.47)]. Quenched samples were immediately frozen on dry ice until 
required for liquid chromatography/mass spectrometry analysis. Quenched 
samples were rapidly thawed and injected into a Waters nanoACQUITY with 
HDX technology55 for online pepsin digestion and ultraperformance liquid 
chromatography separation of the resulting peptic peptides and were 
analyzed as reported previously56. All mass spectra were acquired with a 
WATERS SYNAPT G2 HDMS mass spectrometer. The data were analyzed 
with DynamX 2.0 software. Relative deuterium amounts for each peptide 
were calculated by subtracting the average mass of the undeuterated control 
sample from that of the deuterium-labeled sample for isotopic distributions 
corresponding to the + 1, + 2, or + 3 charge state of each peptide. The data 
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were not corrected for back exchange and are therefore reported as relative 
values57,58. Differences larger than 0.4 Da are considered subtle while those 
larger than 0.8 Da are considered obvious, according to the statistical criteria 
for relative HDXMS measurements previously described59. 
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Figures 
 
 
Fig. 1. MD simulations reveal differences between the Btk and Lck kinase 
domains. 
 (a) Structure of a kinase domain in the active conformation. Key 
structural motifs that stabilize the active state are indicated. The regulatory 
spine residues are orange and indicated with the dotted line, the DFG motif 
and conserved Lys/Glu salt bridge are circled, the αC helix is in the αC-in 
conformation, and the activation loop tyrosine is phosphorylated (pY) and 
contacting the conserved arginine. (b) We performed 100-ns equilibrium 
simulations for (b) active Lck (PDB ID 3LCK; residues 239–501) and (c) 
active Btk (PDB ID 3K54; residues 396–659). RMSD from the starting 
structure is reported for select regions of each kinase domain: the amino-
terminal lobe (N-lobe), the carboxy-terminal lobe (C-lobe), the regulatory 
spine (R-spine), and the αC helix. The distance (Å) between the 
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lysine/glutamate side chains (K273/E288 for Lck and K430/E445 for Btk) are 
shown over the course of the simulations. Replica 1 is shown in black; 2, in 
dark gray; and 3, in light gray. Snapshots of the catalytic core during the 
simulations from replica 1 of Lck and replica 1 of Btk are shown at 0 ns, 
10 ns, 20 ns, 30 ns, 40 ns, 50 ns, and 100 ns. For each structural 
superposition, the lysine and glutamate side chains are red and blue, 
respectively; the regulatory spine residues are orange and the αC helix and F 
helix are labeled. 
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Fig. 2. Mutation of I432 to leucine relieves the “inactive by default” status of 
the Btk kinase domain. 
 (a) In vitrokinase assays for His6-tagged Btk kinase domain variants 
[wild-type (WT) Btk kinase domain], three single Btk kinase domain mutants 
(Btk I432L, Btk E439P, and Btk E441A), and the Btk kinase domain triple 
mutant [Btk IEE/LPA (I432L/E439P/E441A)]. Btk activity is monitored by 
autophosphorylation using the anti-phosphotyrosine antibody, anti-pY551, 
that is specific for phosphorylation on the activation loop (pY551) of Btk. 
Tyrosine phosphorylation levels were quantified and normalized to total 
protein in each lane (pY551 for wild-type Btk kinase is set to 1). In (a) to (d), 
KD refers to the isolated Btk kinase domain. (b) Initial velocity measurements 
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for wild-type Btk kinase domain (Btk WT) and the Btk I432L kinase domain 
mutant (Btk I432L) using the poly (4:1 Glu,Tyr) peptide substrate. (c) Same 
experiment as shown in (a) comparing autophosphorylation of Btk kinase 
domain Y617P and Btk kinase domain Y617P/I432L following overnight 
incubation with ATP. Coomassie staining is used to show enzyme levels. (d) 
Peptide substrate curves for Btk kinase domain Y617P (circles) and Btk 
kinase domain Y617P/I432L (squares) were fit to the Michaelis–Menten 
equation using GraphFit to obtain kinetic parameters. 
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Fig. 3. Btk I432L behaves similar to Lck kinase domain in MD simulations. 
(a) We performed 50-ns equilibrium simulations for Btk I432L. RMSD 
from the starting structure is reported for select regions of the kinase domain 
as in Fig. 1b and c. Replica 1 is shown in black; replica 2, in dark gray. (b and 
c) Snapshots of the 0 and 50 ns time points from the simulation of Btk I432L 
(b) and wild-type Lck (c). The side chains for the phenylalanine on the αC 
helix (F442 for Btk and F285 for Lck) and adjacent to the αC helix [I314 (Lck), 
L275 (Lck), and I472 (Btk)] are shown in red and labeled. The site of mutation 
in Btk is labeled as I432L and the side chain in the structure is the non-native 
leucine. The chi1 dihedral angle is defined by N-Cα-Cβ-Cγ for leucine (N-Cα-
Cβ-Cγ1 for isoleucine). 
	   65	  
 
 
Fig. 4. Isoleucine and leucine side-chain rotamer preferences differ between 
wild-type Btk and the Btk I432L mutant. 
 (a) I432 chi1 angles are shown during the Btk kinase domain 
simulation. Gauche(+) and gauche(−) are indicated at + 60° and − 60°, 
respectively. The preference for gauche(+) and gauche(−) in the Btk 
simulations is consistent with the probabilities of isoleucine rotamers 
observed in analyses of rotamer libraries60. (b and c) Newman projections for 
each isoleucine chi1 rotamer are shown above snapshots from the 
simulations showing I432 in the gauche(+) rotamer conformation (b) and the 
gauche(−) rotamer conformation (c). (d and e) chi1 angles for (d) L275 of Lck 
and (e) L432 of the Btk I432L mutant shown over the course of the simulation. 
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chi1 angles shown are from a single replicate and are representative of all 
simulations for each protein. (f) Newman projection for the trans leucine chi1 
rotamer is shown above the crystal structure of the Lck kinase domain (3LCK) 
showing the trans rotamer for L275. 
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Fig. 5. Isoleucine 432 in the Btk kinase domain sterically blocks the αC-in 
conformation associated with the active kinase domain. 
(a) Model describing the proposed steric wedge created by specific 
rotamer conformations of I432 in the isolated Btk kinase domain. In inactive 
Btk, the αC helix samples a smaller range of conformations that favor αC-out 
(small gray double-headed arrow). The intermediate state indicates that the 
putative steric block created by I432 can be relieved either by mutation to 
leucine (favoring the trans rotamer) or by a shift to the isoleucine trans chi1 
rotamer (indicated by black arrow). The rotamer shift for the I432 side chain 
may be energetically favored by association of the Btk regulatory domains 
with the N-lobe of the kinase domain. In the active state, the αC helix samples 
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greater conformational space including the αC-in conformation (large gray 
double-headed arrow). (b and c) Comparison of (b) full-length Btk (Btk FL 
Y617P) and full-length Btk containing the I432L mutation (Btk FL 
Y617P/I432L) and (c) isolated Btk kinase domain (Btk KD Y617P) and 
isolated Btk kinase domain containing the I432L mutation (Btk KD 
Y617P/I432L). In both experiments, the top panel shows activation loop 
phosphorylation levels (pY551) prior to incubation with ATP and the middle 
panel shows pY551 levels after incubation with ATP. Bottom panel shows 
enzyme levels. 
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Fig. 6. NMR spectroscopy and simulation data suggest differences in the 
DFG motif between wild-type Btk and the Btk I432L mutant. 
 (a) 1H-15N TROSY HSQC spectrum of uniformly 15N-labeled Btk 
kinase domain. The amide resonance for F540 is labeled in the complete 
spectrum and labeled in the region of the spectrum shown in inset. (b) 1H-15N 
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TROSY HSQC spectrum of uniformly 15N-labeled Btk I432L kinase domain. In 
this spectrum, the resonance for F540 is not detected (red box indicates 
expected position of the F540 amide peak; no new peaks appear suggesting 
line broadening rather than a change in chemical shift). (c) Left: structure of 
the DFG motif in the Btk crystal structure. The side chains of D539, F540, and 
G541 are labeled and the carboxylate of the D539 side chain and the NH 
group of G541 are circled. Right: the distance (Å) between the carboxylate 
oxygen (Oδ1) of D539 and the amide nitrogen (N) of G541 is plotted for the 
three replicates of the 100-ns Btk simulations. (d) Left: structural snapshot 
from the Btk I432L simulation showing the conformation of the DFG motif at 
36 ns. The short distance (3.2 Å) between D539 Oδ1 and G541 N is shown 
with a dotted line. Right: same as described for (c) showing the D539 Oδ1–
G541 N distance for two replicates of the 50-ns Btk I432L simulations. 
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Fig. 7. HDXMS indicates increased conformational flexibility in the active Btk 
I432L mutant. 
 (a) HDXMS results are illustrated on the structure of the Btk kinase 
domain. The Btk structure used here is the inactive conformation (3GEN) 
since the activation loop is visible in this structure. Increased deuterium 
uptake is seen in the Btk I432L mutant for regions shown in red (greater than 
0.8 Da increase in mass) and orange (0.5–0.8 Da increase in mass). The side 
chains of I432 and Y551 (phosphorylation site on the activation loop) are 
labeled and colored cyan. (b–d) Deuterium exchange was measured for the 
WT Btk kinase domain (blue squares) and Btk I432L (red circles) and data 
were plotted as relative deuterium incorporationversus time for peptides 
covering specific regions of secondary structure within the N-lobe (b), DFG 
motif (c), and the N-terminus and C-terminus of the Btk activation segment 
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(d). The data are an average of two independent labeling replicates. Error 
bars shown indicate the absolute range of relative deuterium level and in 
most cases are within the size of the data point. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   73	  
Supplementary Figures 
 
 
 
Supp. Fig. S1.  
(a) Complete analysis of the Lck and Btk simulations. (b) Snapshots at 
0, 10 and 20 ns for the Btk simulation (replicate 1) showing the starting 
structure at 0 ns with both the K430-E445 and the R544-pY511 interactions 
intact. Both electrostatic interactions are broken around 10 ns. At 20 ns, the 
R544-E445 salt bridge characteristic of the inactive kinase conformation has 
formed. 
b	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Supp. Fig. S2. Analysis of side chain packing interactions for the αC helix in 
Btk.  
(a) Histogram showing the number of highly frustrated (red) versus 
minimally frustrated (blue) pairwise contacts for the αC helix residues in the 
Btk simulation at 0, 10 and 100 ns. Values from each of the three replicates at 
10 and 100 ns were averaged and errors bars reflect the minimum and 
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maximum number of contacts in each case. (b) The four residues on the αC 
helix that are highly frustrated early in the simulation are shown in red and 
labeled. Frustration Index for each side chain (F442, E439, E445 and E441) 
is as follows (pairwise contact, Frustration Index): F442 (E445, - 1), E439 
(E441, -1.7; E444, -1.7; E445, -1.6; P469, -1.4), E445 (K447, -1.4; D539, -1.4; 
G541, -1.1; S543, -1.1), E441 E444, -1.8; E445, -1.5; G541, -1.1). (c) 
Structure of the Btk kinase domain showing residues within 6 Å of F442 and 
E445 on the αC helix. F442 and E445 on the αC helix are red and 
surrounding side chains are orange. I432 (circled) is conserved among the 
Tec kinases and not present in the Src family kinases. (d) Btk I432L 
simulations are shown in black (replica 1) and gray (replica 2). The bottom 
two panels monitor salt bridge distance for the active salt bridge (K430-E445 
in Btk) and inactive salt bridge (E445-R544 in Btk); all other panels measure 
RMSD for the indicated structural features. Unlike the wild-type Btk 
simulations, Btk I432L maintains the active αC-in position of the αC helix, 
stabilizing the active conformation during the course of the 50 ns simulations. 
Snapshots of the catalytic core during the simulations from both replicates of 
Btk I432L: the structural superpositions shown are for 0ns, 10ns, 20ns, 30ns, 
40ns, 50ns, and 100ns. For each structure the lysine and glutamate side 
chains are shown in red and blue, respectively, the regulatory spine residues 
are orange and the αC helix and F helix are labeled. 
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Supp. Fig. S3. Thermal denaturation curves.  
(a) Normalized fluorescence emission data measured in triplicate 
(solid, dashed and dotted lines) for the Btk kinase domain Y617P (red) and 
Btk kinase domain Y617P/I432L double mutant (blue) is shown. The solid 
black trace shows the fluorescence of Sypro Orange alone without protein. (b) 
Normalized inverse first derivative of the data in panel ‘a’ shows a decrease in 
the Tm for the Btk kinase domain Y617P/I432L mutant (Tm = 43 °C) 
compared to the Btk kinase domain Y617P (Tm = 44.5 °C). 
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Supp. Fig. S4. Relative loss in protection from exchange for the Btk kinase 
I432L mutant compared to the wild-type Btk kinase.  
Changes in deuterium uptake at 5 different time points are shown as 
horizontal bars: 10 seconds (orange), 1 min (red), 10 min (cyan), 1 h (gray) 
and 4h (dark blue). The sequence of each peptide is shown on the right. 
Changes beyond the blue dotted line at 0.5 Da (in either direction) and in the 
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area shaded in blue are considered to be moderate changes. Changes 
beyond the dotted green line are designated as significant changes. Data is 
an average over two independent labeling replicates. 
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Abstract 
Bruton’s tyrosine kinase (Btk) is a Tec family non-receptor tyrosine 
kinase that plays a critical role in immune signaling and is associated with the 
immunological disorder X-linked agammaglobulinemia (XLA). Our previous 
findings showed that the Tec kinases are allosterically activated by the 
adjacent N-terminal linker. A single tryptophan residue in the N-terminal 17-
residue linker mediates allosteric activation, and its mutation to alanine leads 
to the complete loss of activity. Guided by hydrogen/deuterium exchange 
mass spectrometry results, we have employed Molecular Dynamics 
simulations, Principal Component Analysis, Community Analysis and 
measures of node centrality to understand the details of how a single 
tryptophan mediates allostery in Btk. A specific tryptophan side chain rotamer 
promotes the functional dynamic allostery by inducing coordinated motions 
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that spread across the kinase domain. Either a shift in the rotamer population, 
or a loss of the tryptophan side chain by mutation, drastically changes the 
coordinated motions and dynamically isolates catalytically important regions 
of the kinase domain. This work also identifies a new set of residues in the 
Btk kinase domain with high node centrality values indicating their importance 
in transmission of dynamics essential for kinase activation. Structurally, these 
node residues appear in both lobes of the kinase domain. In the N-lobe, high 
centrality residues wrap around the ATP binding pocket connecting previously 
described Catalytic-spine residues.  In the C-lobe, two high centrality node 
residues connect the base of the R- and C-spines on the αF-helix.  We 
suggest that the bridging residues that connect the catalytic and regulatory 
architecture within the kinase domain may be a crucial element in transmitting 
information about regulatory spine assembly to the catalytic machinery of the 
catalytic spine and active site.    
 
Introduction  
 Kinase domains consist of a bi-lobal structure, the N- and C-lobes, 
which together create the catalytic site to transfer a phosphate from ATP to a 
substrate hydroxyl (Fig. 1a)1,2. Transition between active and inactive kinase 
structures involves concerted motions of specific regions of secondary 
structure.  For example, the αC-helix in the N-lobe adopts a ‘C-out’ 
conformation in the inactive state and shifts to a ‘C-in’ conformation when the 
kinase is activated. This transition is triggered by phosphorylation of specific 
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residues in the activation loop that cause a switch in a number of electrostatic 
interactions.  Moreover, the αF-helix in the C-lobe supports two separate 
regulatory motifs (the Catalytic (C)-spine and Regulatory (R)-spine)3,5 (Fig. 
1b). The residues that make up these spines are conserved and their proper 
assembly is required for kinase activation. Identification of these spines has 
provided a model for kinase activation that explains how phosphorylation at 
regulatory sites on the activation loop triggers subsequent conformational 
rearrangements that stabilize the active kinase domain3,5. 
 
 The Tec family of non-receptor tyrosine kinases, Btk, Itk, Tec, Bmx and 
Rlk, are regulators of immune cell function6,7. Tec kinase mutations have 
been linked to immunodeficiencies and lymphoproliferative diseases8,9. For 
example, genetic defects leading to single amino acid changes in Btk cause 
XLA, a condition characterized by a lack of mature B cells and hence a 
complete lack of circulating antibodies. A clear understanding of Tec family 
regulation is a critical step needed prior to developing improved 
immunotherapies.   
 
Consistent with the R-spine model, we have found that individual 
mutation of each of the R-spine residues in Itk disrupts catalytic activity10. 
However, we have also found that the isolated Itk and Btk kinase domains 
have reduced activities compared to the corresponding full-length enzymes11. 
This suggests that even when these kinase domains are requisitely 
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phosphorylated at the regulatory tyrosine, the active conformation (containing 
an assembled R-spine) is not sufficiently stable. Indeed, crystal structures of 
the phosphorylated Itk kinase domain reveal a disassembled R-spine12.  
 
 Stabilization of the catalytically competent conformation must require 
specific contacts between residues outside of the kinase domain and the 
kinase domain itself to overcome the innate conformational preference of the 
isolated Tec family kinase domain for the inactive state11,13. Mutagenesis 
experiments identified a conserved tryptophan (W395 in Btk) in the region 
preceding the kinase domain that is absolutely required for kinase activity 
(Fig. 1c). This tryptophan plays the opposite role in the Src family kinases 
where it instead functions as a wedge, preventing the inward motion of αC-
helix to the active ‘C-in’ state, thus stabilizing the inactive conformation of the 
kinase domain. Quite unlike the Tec family kinases (Fig. 1c), mutation of this 
conserved tryptophan in Src kinases relieves the steric hindrance imposed by 
its side-chain resulting in a shift in the conformational equilibrium to the active 
state11,14.  
 
In our earlier work, we proposed that the tryptophan ‘caps’ the top of 
the regulatory spine of the Tec family kinases providing essential contacts 
that stabilize the assembled R-spine structure11. Here, we combine results 
from hydrogen-deuterium exchange mass spectrometry (HDXMS) and 
Molecular Dynamic (MD) simulations to develop a more detailed mechanistic 
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understanding for how the linker tryptophan drives the conformational 
equilibrium and dynamic sampling of the Btk kinase domain toward the active 
state.  
  
Results 
W395 exerts a positive allosteric effect within the linker-kinase domain 
fragment of Btk. 
To probe the role of W395 in stabilizing the active form of the Btk 
kinase domain, we first assessed the effect of the W395A mutation within the 
fragment of Btk containing the kinase domain and N-terminal linker, residues 
382-659 (Fig. 2a). The wild type sequence is referred to as the Btk linker-
kinase and was compared throughout this work to the same Btk fragment 
bearing the single tryptophan to alanine mutation: Btk (W395A) linker-kinase. 
The loss of activity observed upon mutation of W395 to alanine in the context 
of the Btk linker-kinase fragment (Fig. 2b) mirrored that of full length Btk (Fig. 
1c), making this fragment a reasonable model for studies to investigate the 
role of W395 in controlling Btk catalytic activity.  
 
Deuterium exchange reveals dynamic differences between wild type and 
mutant Btk linker-kinase. 
HDXMS allows detection of backbone amide hydrogens for each 
amino acid in the protein (except proline) permitting direct comparison of the 
combined effects of solvent accessibility and hydrogen-bonding of amide N-H 
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groups between two proteins. Btk linker-kinase and Btk (W395A) linker-kinase 
were subjected to identical experimental conditions allowing for exchange of 
deuterium with the labile amide hydrogens15. The H/D exchange reaction was 
quenched and the proteins were proteolyzed to yield peptides for analysis by 
mass spectrometry. Differences in deuterium exchange between wild type 
and the W395A mutant of Btk linker-kinase localize to the aC-helix and the N-
terminal region of the activation segment (Fig. 2c) with no significant 
differences throughout the rest of the kinase domain (Supp. Fig. S1). For the 
peptides derived from the aC-helix and activation segment, deuterium uptake 
was greater for the wild type Btk linker-kinase protein compared to the 
W395A mutant (Fig. 2d,e). This observation is consistent with previous H/D 
exchange data showing that a more active kinase undergoes greater 
conformational sampling and thus greater exchange with bulk solvent16,17.   
 
HDXMS data for wild type Btk linker-kinase and Btk (W395A) linker-
kinase also suggest that the linker and N-terminal region of the kinase domain 
are not perturbed by the W395A mutation (Fig. 2f). The sequence adjacent to 
W395 (E396IDPKDLT403) was protected from exchange at early time points 
suggesting that this region associates with the N-lobe regardless of the 
presence or absence of the tryptophan side chain. Crystal structures of active 
and inactive Btk kinase domain containing the linker region indicate a single 
structural difference in this region; the W395 side chain adopts distinct chi1 
rotamers in each structure (Fig. 2g). These data suggest that in one rotameric 
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configuration, W395 might regulate catalytic activity by increasing the 
dynamic motions of the adjacent kinase domain and specifically promoting 
more frequent conformational sampling of the aC-helix and activation 
segment near the active conformation, while the other rotamer moves the 
W395 side-chain away from the kinase domain thereby altering the 
environment of the aC-helix and thus the kinase domain dynamics. Mutation 
of W395 to alanine mimics the inactive state by removing the large side chain 
from the proximity of the aC-helix. To gain further insight into the allosteric 
role of Btk W395, we next compared all-atom MD simulations between the 
active Btk linker-kinase domain fragment and the inactive mutant Btk 
(W395A) linker-kinase domain.  
 
Molecular Dynamics Simulations capture the activating effect of W395. 
MD simulations are widely used to investigate the differences in 
conformational dynamics of mutant and wild type protein structures14,18,19. 
The application of MD simulations in this study aims to capture the effect of a 
single point mutation on the active state of the Btk linker-kinase domain. PDB 
ID 3K5420 was used to derive the starting active conformation of Btk linker-
kinase domain. A detailed description of model building and mutation of W395 
to alanine is provided in Methods. Three replicates of MD simulations were 
carried out for 200 ns for each protein model and, guided by the HDX data, 
we compared the RMSD changes for the αC-helix and the activation segment 
(Fig. 3). The αC-helix remained in the active “C-in” conformation for the 
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duration of the simulation of wild type Btk linker-kinase (Fig. 3a,e) but 
transitioned from the active “C-in” to inactive “C-out” conformation at early 
time points in the simulation of inactive Btk (W395A) linker-kinase (Fig. 3b-
d,f). The αC-helix transition captured in the Btk (W395A) linker-kinase 
simulation led to loss of the K430/E445 salt bridge and concomitant changes 
in the electrostatic contacts between R544 and pY551 (Fig. 3f). In contrast, 
the distance between the K430/E445 and R544/pY551 side chains remained 
constant throughout the wild type Btk linker-kinase domain simulations (Fig. 
3e). Consistent with conformational changes localized to the regulatory 
regions in the N-lobe, the RMSD of total backbone atoms of Btk linker-kinase 
domain and Btk (W395A) linker-kinase showed only small changes 
throughout the simulation time (Fig. 3a-d).   
 
The N-terminal region of the activation segment (residues 540-547) 
also behaved differently in simulations of wild type Btk linker-kinase versus 
(W395A) linker-kinase domain (Fig. 3a-d). The activation segment sampled 
conformations near the active state during the simulation of the Btk linker-
kinase domain (Fig. 3a). In contrast, the activation segment in Btk (W395A) 
linker-kinase drifted to a greater extent from the starting active conformation 
as indicated by the greater RMSD from its starting active conformation (Fig. 
3b-d). The DFG motif at the N-terminal end of the activation segment retained 
its active conformation during the simulation of the Btk linker-kinase domain 
but reverted to the conformation seen in the crystal structure of inactive Btk in 
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simulations of Btk (W395A) linker-kinase (Fig. 3f). The activation loop as a 
whole, however, did not transition into the inactive conformation seen in the 
crystal structure of inactive Btk (3GEN) likely due to the length of simulation 
time and the fact that the activation loop tyrosine, Y551, is phosphorylated in 
the simulations (Fig. 3f). Overall, the conformational changes observed in the 
simulations of Btk (W395A) linker-kinase domains suggest that the mutant 
kinase is not stable in the active conformation, consistent with the 
experimental observation that the side-chain of W395 plays a critical role in 
maintaining the active conformation of the Btk kinase domain.  
 
W395A changes the dominant motions within the Btk kinase domain. 
Principal Component (PC) Analysis (Fig. 4, Supp. Figs. S2&S3) 
reveals the important motions in the system that might otherwise be obscured 
by the small fluctuations within a trajectory21. The first few PCs can capture a 
large fraction of the variance in the data and thus represent the dominant 
motions. We calculated the root mean-square inner product (RMSIP) between 
the first 10 PCs from each of the trajectories for Btk linker-kinase and of 
trajectories for Btk (W395A) linker-kinase domain to determine how well the 
PC subspace overlaps between the different replicates. Large RMSIP values 
were seen between the subspaces covered by first 10 PCs from each of the 
replicates for both Btk linker-kinase and Btk (W395A) linker-kinase domain 
simulations (Btk linker-kinase domain, rep1 vs rep2: 0.73, rep1 vs rep3: 0.7, 
rep2 vs rep3: 0.68. Btk (W395A) linker-kinase domain, rep1 vs rep2: 0.68, 
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rep1 vs rep3: 0.66, rep2 vs rep3: 0.64), indicating that there is high similarity 
between the sets of PCs derived from each of the individual replicates. The 
first three PCs in Btk linker-kinase and Btk (W395A) linker-kinase domain 
simulations captured 43.37% and 79.8%, respectively, of the total variance 
observed in the simulation data (Fig 4a,c). The dominant motion within Btk 
linker-kinase domain, as captured by the first three dominant principal 
components include an opening-closing motion of the N- and C-lobes around 
a hinge (Fig 4b, PC2). A similar ‘breathing’ motion was described for other 
active kinases4,22,23, suggesting this is a shared feature of catalytically 
competent kinases and may be responsible for the greater amide NH 
accessibility observed for the active protein with HD exchange methods. 
Indeed, this ‘breathing’ motion is considered important for the structural 
rearrangement of the αC-helix and activation segment to assemble the active 
site and is considered necessary for the release of ADP after the reaction is 
complete4,24. Overlap between PCs derived from the three replicates of each 
Btk linker-kinase shows that high overlap exists between PCs capturing the 
‘breathing’ motion (Supp. Fig. S4a). In contrast, the dominant mode in the Btk 
(W395A) linker-kinase domain simulation, captured almost entirely by its PC1, 
shows a combination of twisting and translation motion of the N- and C-lobes 
(Fig. 4d) quite similar to that seen in simulations of other inactive kinases22,23. 
Overall, differences in PCs are consistent with the conclusion that W395A 
alters the global motions of the Btk kinase domain.  
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PCA was also performed by combining the three simulation replicates 
of Btk linker-kinase together with the Btk (W395A) linker-kinase domain by 
aligning to the same reference structure to compare the overlaps between the 
simulation trajectories along the PC1-PC2-PC3 of this collective subspace 
(Supp. Fig. S4g). It is clear from the distribution of the trajectories that the 
mutant Btk (W395A) linker-kinase domain (Supp. Fig. S4h-j) samples a sub-
space that is mostly different from that sampled by the wild-type Btk linker-
kinase domain (Supp. Fig. S4k-m) but does include sampling of a part of the 
sub-space similar to the wild-type Btk linker-kinase.  
 
Community analysis reveals dynamic coupling throughout the kinase domain 
is lost on mutation of W395 to alanine. 
PCA provided a broad picture of the relative motions of the N- and C-
lobes for the wild type structure and for the mutant W395A.  To identify 
dynamic sub-segments within each lobe of the Btk kinase domain, we next 
examined the correlation of motions of residue pairs within the kinase domain 
of Btk linker-kinase and the (W395A) linker-kinase mutant.  Cα coordinates 
were used for this analysis, as coarse-grained models have proven valuable 
in capturing the intrinsic dynamics of proteins25,26. The cross-correlation 
coefficients for Btk linker-kinase and Btk (W395A) linker-kinase were used to 
build dynamic cross-correlation maps to examine the differences in the 
correlated motions that remain within 10 Å for 75% of the simulation time 
(Supp. Fig. S5). The 10 Å cutoff was chosen as it has been found to be the 
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optimal cutoff for modeling interactions in coarse grained models as well as 
for comparison of our results with community analysis results of other active 
kinases such as PKA27. The cross-correlations were then used to build a 
correlated network of residues; represented as a set of connected circles 
(communities) with the weight of the lines connecting each community 
proportional to the degree of their correlation (Fig. 5, Supp. Fig. S6a,b). The 
residues of wild type Btk linker-kinase and Btk (W395A) linker-kinase 
clustered into distinct communities (Fig. 5a,b), reflecting difference in the 
dynamic sub-segments of the active versus inactive kinase domain.   Detailed 
summaries of the communities are provided in Supp. Fig. S7. Where 
possible, we have labeled the communities (Com) in Btk linker-kinase in a 
manner similar to those described by McClendon and co-workers in their 
community analysis of PKA27. 
 
Community clustering based on cross-correlations identified two major 
communities, ComA, and ComC, in the Btk linker-kinase domain N-lobe (Fig. 
5a). All of the linker residues including W395 are part of ComA, which also 
contains beta strands β1, β2, β3, β4 and β5, regulatory spine residue L460 
and the Gly-rich loop. ComC includes the important αC-helix and the R-spine 
residue M449.  Separate from the αC-helix, the aC-b4 loop segregates with 
ComD, which extends into the C-lobe and includes the hinge region of the 
kinase domain. The catalytic loop HRD motif including the R-spine residue 
H519 and the N-terminus of the activation segment, which includes the 
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regulatory spine residue F540 (part of the DFG motif) are clustered in ComP. 
The grouping of disparate regions of the kinase domain into communities A, 
C, D and P points to dynamic coordination in the active Btk linker-kinase 
domain.  Indeed, the assembled R-spine residues reside in four different 
communities demonstrating the correlation of this structure to different 
regions in the active kinase domain. 
 
It is immediately evident that there are fewer communities within Btk 
(W395A) linker-kinase domain and the correlations between these 
communities are weaker compared to those of the wild type Btk linker-kinase 
protein (Fig. 5b). This result suggests that a mutation that inactivates the 
kinase domain may do so by reducing as well as dampening correlated 
motions within the protein. The integrity of ComC was lost in the Btk (W395A) 
linker-kinase domain, where the αC-helix itself is divided into two dynamically 
distinct communities ComL and ComE.  The aC-b4 loop in the inactive Btk 
(W395A) linker-kinase is in ComE, which is separated from the hinge region 
in ComI. The R-spine residues within Btk (W395A) linker-kinase are 
dynamically isolated in ComE, which is only weakly linked to other structurally 
significant regions of the kinase domain (Fig 5b). Comparing community 
analysis of the wild type and mutant Btk kinases indicates that loss of the 
single W395 side-chain results in a breakdown of the “signal integration” 
function27,28 of the αC-helix across the two lobes of the kinase with R-spine 
assembly and dynamics being adversely affected.  
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Specific residues mediate allosteric communication. 
To identify specific residues responsible for the allosteric 
communication between W395 and the rest of the kinase domain, we next 
computed the node-betweenness centrality index for each residue within both 
the wild type Btk linker-kinase (Fig. 6a) and the Btk (W395A) linker-kinase 
(Fig. 6b). Centrality index is a measure of the number of shortest paths that 
pass through a node, which is a direct measure of the contribution of the node 
to the total communication flow in the system29,30. High centrality values 
correlate with the importance of these nodes in the transmission of 
information through the network. This analysis therefore identifies residues 
that act as hubs in the allosteric communication pathway transmitting the 
activating effect of W395 throughout the Btk kinase domain.  
 
Four residues, Y476, M477, L522 and F583 within the active Btk linker-
kinase domain exhibit high centrality while in Btk (W395A) linker-kinase 
domain only two residues, Y476 and G480, are above the same threshold 
centrality value (Fig. 6a,b). In wild type active Btk the hub residues are 
located in two regions, Y476 and M477 appear to complete the C-spine and 
wrap around ATP pocket in the N-lobe (Fig. 6d,e) and L522 and F583 are 
situated between the base of the C- and R-spines in the C-lobe (Fig. 6d,e).  
The location of L522 and F583, in particular, suggest a bridging role where 
these residues might function to communicate R-spine assembly to the C-
spine and the ATP bound active site.  Along these lines it is interesting to note 
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that while M477 and L522 are 14Å apart and are located in different lobes of 
the kinase domain, they both belong to ComD (Fig. 5a) suggesting a central, 
and correlated, role in the allosteric dynamics of kinase activation.   
 
The now well recognized C- and R-spines are a shared feature of the 
kinase family and so we wished to assess whether similar bridging residues 
would be detected in another active kinase domain.  Simulation data acquired 
previously for the Src family tyrosine kinase, Lck17 were used to compute the 
centrality index values for each residue of the active Lck kinase domain.  A 
set of Lck residues with high centrality values emerged (Fig. 6c) that are quite 
similar to those found for Btk (Fig. 6a). The high centrality Lck residues 
include Y318 and M319 that correspond exactly to Y476 and M477 in Btk 
(Fig. 6f).  As well, Lck residues R366 and S425 are located between the base 
of the C- and R-spines in a manner similar to L522 and F583 in Btk.  Two 
additional Lck residues in the C-lobe, W424 and W477, reach the high 
centrality threshold and the C-spine residues I370 and L371 exhibit high 
centrality in Lck. The fact that a similar arrangement of high centrality 
residues are identified in two different active kinases and that a subset of 
these residues bridge the R- and C-spines provides further support for a 
mechanistic model for activation whereby regulatory spine assembly may be 
dynamically communicated to the catalytic apparatus of the active site.  
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Discussion  
Tryptophan 395 is a positive regulator of Btk kinase activity11.  In 
contrast to the negative regulatory role of the same tryptophan in the Src 
family kinases14,31, mutation of this single residue abolishes the catalytic 
activity of the 70 KDa full-length Btk kinase.  Our experimental and 
computational findings provide an explanation for the positive allostery 
observed for the Tec family and suggest that a particular conformation of the 
W395 side-chain promotes long range correlated dynamic motions throughout 
the kinase domain that are essential for catalytic activity.   
 
MD simulations indicate that the Btk aC-helix samples the ‘C-in’ state 
for the majority of the trajectories when W395 adopts the rotameric 
conformation observed in the crystal structures of active Btk.  In contrast, the 
absence of the W395 side-chain, achieved either by a rotameric shift or by 
mutation to alanine, favors the ‘C-out’ state.  The conformational preferences 
of the aC-helix are linked to the overall motions of the N- and C-lobes of the 
kinase domain, as well as to the degree of correlation between residues 
throughout the kinase domain. Based on the computational work presented 
here and by others27,32,33, and previous analyses of active and inactive 
kinases by NMR spectroscopy34,36, it is becoming clear that the active state of 
a kinase domain requires a specific highly dynamic, interconnected structure. 
The inactive kinase exhibits substantially less cohesion, with fewer correlated 
motions throughout the kinase domain when motions are compared with 
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those of the active form. Moreover, the hydrogen/deuterium exchange data 
indicate that specific regions of the wild type Btk linker-kinase domain sample 
more open conformations compared to the Btk (W395A) linker-kinase mutant, 
consistent with the view that inactivating mutations suppress the dynamics 
required for catalytic activity.  
 
While it may be tempting to explain allostery in terms of a simple 
pathway leading from the W395 side-chain to the kinase active site, our 
findings, as well as the work of others27,32,37, argue against a simple linear 
allosteric pathway.  In a recent review focusing on dynamics and allostery 
within the protein kinases38, Kornev and Taylor drew an elegant analogy 
between the kinase domain and the violin, invoking the vibrations responsible 
for the tone and pitch emanating from a violin as a way to think about the role 
of molecular dynamics in controlling the catalytic activity of the enzyme38.  
Small, localized changes on the violin, such as placing a finger on a string, 
can have a dramatic effect on the resulting pitch by altering the vibrations of 
the entire instrument.  Amino acid mutations are similarly likely to affect 
protein function by altering the long range correlated motions throughout a 
structure, and changes at particular positions may critically affect function. 
Indeed, our data suggest that the inactivating W395A mutation substantially 
dampens the dynamics of the Btk kinase domain in much the same way that 
muting restricts vibrations throughout a violin by reducing the volume of the 
notes.   
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Community analysis39 provides insight into changes in correlated 
motions that result from ligand binding and/or amino acid mutation27,32,33,40,41. 
The set of communities identified within Btk are similar to those defined 
previously for PKA27.  In both, the communities contain residues from distant 
regions of the primary structure and connections between certain 
communities are strong, indicating that correlations within an active kinase 
are spread throughout the kinase domain. Analyses of inactive Btk mutants 
reveal fewer communities that are less coherent indicating that the correlated 
motions typical of an active kinase are absent in the inactive state.   
 
We have extended our analysis separately to the Btk linker-kinase and 
the Btk (W395A) linker-kinase to include computation of the residue specific 
node-betweenness centrality index42. A higher centrality indicates that a 
residue serves as a node or hub, playing a greater role in information flow in 
the network. In the active Btk linker-kinase and Lck kinase domains, specific 
residues across the primary structure are characterized by high centrality 
values suggesting their involvement in the flow and transmission of dynamical 
information in the active state. The similarity in tertiary structural arrangement 
of these residues in both kinases is compelling and two of the high centrality 
residues in each active kinase are perfectly positioned between the two well-
characterized C- and R-spines suggesting a bridging role. In terms of kinase 
activation, the dynamical consequences of the R-spine assembly (triggered 
by activation loop phosphorylation and a shift to the ‘C-in’ state) may be 
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transmitted to the catalytic machinery of the kinase domain via these bridging 
residues, thereby integrating assembly and catalysis within the active kinase. 
Sequence conservation within each kinase family underscores the importance 
of the bridging residues and for Btk it is noteworthy that all four high centrality 
residues are sites of XLA mutations. Whether these XLA mutations 
specifically disrupt communication between the R- and C-spines to prevent 
kinase activation or simply alter the overall fold and stability of the Btk kinase 
domain remains to be determined.  As was the case with the R- and C-
spines, the true importance of the high centrality residues in each kinase must 
be tested experimentally.  
 
 It is generally challenging to clearly delineate the structural 
consequences of deleterious point mutations. Yet understanding precisely 
how specific mutations disable enzymes can provide the information 
necessary to pursue new strategies toward modulating protein functions for 
therapeutic applications. Here, by combining experiment with pertinent 
simulations we establish the detailed requirements for a particular rotameric 
conformation of a native tryptophan for activity and relate this small region of 
the structure to the dynamics of the entire catalytic unit. We have seen how a 
single point mutation can destroy a protein’s activity by modifying its 
dynamics and allostery. The results found here are consistent with the 
growing realization of the importance of conservation for functional 
dynamics1,38,43,44, and the present case provides strong support for this view.   
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Materials and Methods 
Constructs, protein expression and activity assays  
Baculoviral and bacterial constructs, protein expression and 
purification conditions are described elsewhere11,45. The W395A mutation was 
introduced using site-directed mutagenesis (Stratagene) and verified by 
sequencing. In vitro kinase assays were performed as previously described35.  
 
HDXMS  
Duplicate deuterium labeling experiments were initiated with an 18-fold 
dilution of an aliquot (63 pmoles) of Btk linker-kinase or Btk (W395A) linker-
kinase into a buffer containing 99.9 % D2O, 20 mM Tris, 150mM NaCl, 10% 
glycerol, pD 8.01. The labeling reaction was quenched by addition of quench 
buffer (150 mM potassium phosphate (pH 2.47)]) at 10 secs, 1 min, 10 mins, 
1 hour, and 4 hours. Quenched samples were immediately injected into a 
Waters nanoACQUITY with HDX technology46 for online pepsin digestion and 
ultra performance liquid chromatography (UPLC) separation of the resulting 
peptic peptides, and analyzed as reported previously17. All mass spectra were 
acquired with a WATERS SYNAPT G2si HDMS mass spectrometer. The data 
were analyzed with DynamX 3.0 software. Relative deuterium amounts for 
peptides covering 97.9% of the protein backbone were calculated by 
subtracting the average mass of the undeuterated control sample from that of 
the deuterium-labeled sample for isotopic distributions corresponding to the 
+1, +2, +3, or +4 charge state of each peptide. Data were not corrected for 
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back exchange and are reported as relative values15.  Differences larger than 
0.7 Da are considered obvious, according to the statistical criteria for relative 
HDXMS measurements previously described47.  
 
Structure Preparation  
The coordinates of Btk linker-kinase (PDB ID: 3K54, amino acids: 392-
659) were obtained from the RCSB PDB databank20. The coordinates of the 
bound inhibitor were deleted from the PDB file. The regions missing from the 
electron density maps of 3K54 were modeled with the Loop Model module in 
MODELLER as follows17: amino acids 435-441, which include the β3-αC loop 
and the N-terminus of the αC-helix, were modeled using Csk (PDB ID: 1K9A, 
chain B)48 and Lck (PDB ID:3LCK)49 as templates; amino acids 542-558 which 
form the activation loop are modeled based on Btk (PDB ID:1K2P)50 since 
1K2P contains the activation loop resolved in the open conformation.  Finally, 
none of the available crystal structures of Btk contain the DFG motif in the 
active conformation and so we used the structure of the active Lck kinase 
domain (PDB ID:3LCK) to model the active DFG-in conformation into Btk 
3K54. The mutate_model module in Modeller was used to mutate W395 to 
alanine in Btk linker-kinase domain model to derive Btk (W395A) linker-kinase 
domain. Phospho-Tyrosine patch TP2 was used to introduce phosphorylation 
of Y551 in both models.        
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Simulation setup  
The NAMD 2.851 program with CHARMM2752 force field was used to 
initiate all-atom MD simulations of Btk linker-kinase and Btk (W395A) linker-
kinase. The proteins were solvated in a periodic water box with 15 Å buffering 
distance between protein surface and the box, using the TIP3P explicit water 
model. 150 mM concentration of ions (Na+ and Cl- ) was added to charge 
neutralize the system. The systems were equilibrated and simulated in the 
NPT (Normal Pressure Temperature) ensemble at 310 K and 1 atm, using 
Particle-Mesh Ewald for long-range electrostatics. The cutoff used for the van 
der Waals and short-range electrostatics calculations was 12 Å and hydrogen 
bonds were kept rigid using the ShakeH algorithm. The timestep used was 2 
fs.  
 
The prepared simulation systems were minimized according to the 
following steps: (a) 20 picoseconds (ps) minimization of the entire system 
followed by 50 ps of equilibration by holding the protein rigid, allowing only 
water molecules and Na+ and Cl- ions to move. (b) The modeled loops which 
included the Gly-rich loop and the activation segment as well as the β3-αC-
helix loop were subjected to a very short minimization of 2 ps to remove any 
steric clashes. (c) The entire system was minimized, gradually releasing 
harmonic constraints on all protein heavy-atoms. The temperature of the 
system was then gradually raised from 200 K to 310 K with harmonic 
constraints on all protein heavy-atoms, in 5 K increments over a total of 90 ps. 
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Subsequently, the harmonic constraints were gradually released and the 
system was equilibrated for a total time of approximately 1 ns. The production 
MD was run for 200 ns each. The simulations were run in triplicates. 
 
Simulation trajectory analysis  
VMD53 was used to visualize the simulations trajectory and calculate 
Root Mean Square Deviation (RMSD) as well as salt-bridge and hydrogen-
bonding distances. For RMSD calculations, superposition is based on the C-
lobe (N479-S659) using the energy-minimized structure as a reference. 
MATLAB (The Mathworks, Inc.) was used to plot RMSD and distances 
obtained from VMD. Figures were generated with PyMOL54. 
 
Principal Component Analysis  
Cα coordinates of Btk linker-kinase and Btk (W395A) linker-kinase 
domain from 200ns MD trajectory are the input for PCA. PC analysis was 
carried out as described before21. MATLAB was used for the above 
calculations. Directions of motion in PC1-PC3 were mapped onto the 
structure using the modevectors script in pymol54.  To compare the overlap 
between the simulation trajectories, the PC scores were projected along the 
PC1-PC2-PC3 subspace using MATLAB, after combining all the simulation 
trajectories and aligning them to the same reference structure.  Root Mean 
Square Inner Products (RMSIP) between the first 10 PCs in each of the 
replicate of Btk linker-kinase and Btk (W395A) linker-kinase domains were 
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calculated using the Bio3d55 in R56 as described before21. 
 
Cross-Correlation Analysis  
Cross-correlation coefficients indicate whether points in a system move 
in the same or opposite direction and are correlated or move in orthogonal 
directions, in which case the method does not pick up correlations. The Cα 
atoms of each protein were aligned to the first frame of the trajectory. The dot 
products of the displacements Δr of Cα atoms are used in the correlation 
coefficients (Cij) as follows: 
    Ci,j= <Δri•Δrj> 
           
           (|Δri|2|Δrj|2)1/2 
 
 
where Δri denotes the displacement of residue i from the mean. The pairwise 
cross-correlation coefficients between pairs of residues form the elements of 
the cross-correlation matrix. The values of the cross-correlation coefficients 
range between -1 and 1, with -1 denoting negative-correlation, +1 denoting 
positive-correlation and 0 denoting no-correlation. The matrix is depicted as a 
dynamic cross-correlation map (DCCM).  
 
Community clustering and Node-Betweenness analysis 
 The Girvan-Newman clustering algorithm39 was used to identify 
communities of residues from the set of correlated residues obtained above. 
Cross correlation coefficients (Cij) whose absolute values are below the set 
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cutoff of 0.5 were ignored in building the unfiltered DCCM. A proximity/contact 
map filter was applied for building the correlation network of residues for 
those within 10 Å of one another for at least 75% of simulation time27. A 
network is the interconnected set of amino acid residues or nodes. 
Communities are identified using the edge “betweenness” approach, which is 
defined as the number of shortest paths between a pair of nodes (amino acid 
residues). The size of the community is the number of amino acids that have 
a high degree of correlated motion (depicted by size of circle), while the 
thickness of the edges/links connecting the communities denotes the extent 
of correlation.  
 
The middle 100 ns (from 50ns-150ns of total of 200ns) of simulation 
data is used to calculate the centrality as the most prominent conformational 
change in RMSD is observed in the Btk (W395A) linker-kinase domain 
simulation during this time interval. Node-betweenness is an approach 
complementary to edge-betweenness, wherein the number of unique shortest 
paths passing through a node are counted. The cross-correlation analysis, 
community clustering and node-betweenness calculations, were carried out 
using the dccm and cna functions in Bio3d package55 in R56 
 
 
 
	   104	  
Acknowledgments   
The authors thank Alexandr Kornev and Susan Taylor for providing a 
copy of their in press review article and Kannan Sankar for helpful 
discussions throughout the course of this work. Computing resources were 
obtained through a research allocation from the NSF Extreme Science and 
Engineering Discovery Environment (XSEDE) initiative. This work was 
supported by grants from the NIH: AI043957 to A.H.A. & J.R.E., and 
GM072014 to R.L.J and NSF grant MCB-1021785 to R.L.J.   
 
References 
1. Taylor SS, Kornev AP. Protein kinases: evolution of dynamic regulatory 
proteins. Trends Biochem Sci. 2011;36(2):65-77. 
2. Taylor SS, Buechler JA, Yonemoto W. cAMP-dependent protein kinase: 
framework for a diverse family of regulatory enzymes. Annu Rev Biochem. 
1990;59:971-1005.  
3. Kornev AP, Taylor SS, Ten Eyck LF. A helix scaffold for the assembly of 
active protein kinases. Proc Natl Acad Sci U S A. 2008;105(38):14377-82.  
4. Kornev AP, Taylor SS. Defining the conserved internal architecture of a 
protein kinase. Biochim Biophys Acta. 2010;1804(3):440-4.  
5. Kornev AP, Haste NM, Taylor SS, Eyck LF. Surface comparison of active 
and inactive protein kinases identifies a conserved activation mechanism. 
Proc Natl Acad Sci U S A. 2006;103(47):17783-8.  
	   105	  
6. Andreotti AH, Schwartzberg PL, Joseph RE, Berg LJ. T-cell signaling 
regulated by the Tec family kinase, Itk. Cold Spring Harb Perspect Biol. 
2010;2(7):a002287.  
7. Bradshaw JM. The Src, Syk, and Tec family kinases: distinct types of 
molecular switches. Cell Signal. 2010;22(8):1175-84.  
8. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, et al. 
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked 
agammaglobulinemia. Cell. 1993;72(2):279-90. 
9. Huck K, Feyen O, Niehues T, Ruschendorf F, Hubner N, Laws HJ, et al. 
Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to 
protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin 
Invest. 2009;119(5):1350-8.  
10.   Joseph RE, Xie Q, Andreotti AH. Identification of an allosteric signaling 
network within Tec family kinases. J Mol Biol. 2010;403(2):231-42.  
11.   Joseph RE, Min L, Andreotti AH. The linker between SH2 and kinase 
domains positively regulates catalysis of the Tec family kinases. Biochemistry. 
2007;46(18):5455-62.  
12. Brown K, Long JM, Vial SC, Dedi N, Dunster NJ, Renwick SB, et al. 
Crystal structures of interleukin-2 tyrosine kinase and their implications for the 
design of selective inhibitors. J Biol Chem. 2004;279(18):18727-32.  
13.  Joseph RE, Andreotti AH. Conformational snapshots of Tec kinases 
during signaling. Immunol Rev. 2009;228(1):74-92.  
	   106	  
14. Meng Y, Roux B. Computational study of the W260A activating mutant of 
Src tyrosine kinase. Protein Sci. 2015.  
15. Wales TE, Engen JR. Hydrogen exchange mass spectrometry for the 
analysis of protein dynamics. Mass Spectrom Rev. 2006;25(1):158-70.  
16. Burke JE, Perisic O, Masson GR, Vadas O, Williams RL. Oncogenic 
mutations mimic and enhance dynamic events in the natural activation of 
phosphoinositide 3-kinase p110alpha (PIK3CA). Proc Natl Acad Sci U S A. 
2012;109(38):15259-64.  
17. Boyken SE, Chopra N, Xie Q, Joseph RE, Wales TE, Fulton DB, et al. A 
conserved isoleucine maintains the inactive state of Bruton's tyrosine kinase. 
J Mol Biol. 2014;426(21):3656-69.  
18. Ozkirimli E, Yadav SS, Miller WT, Post CB. An electrostatic network and 
long-range regulation of Src kinases. Protein Sci. 2008;17(11):1871-80.  
19. Foda ZH, Shan Y, Kim ET, Shaw DE, Seeliger MA. A dynamically 
coupled allosteric network underlies binding cooperativity in Src kinase. Nat 
Commun. 2015;6:5939.  
20. Marcotte DJ, Liu YT, Arduini RM, Hession CA, Miatkowski K, Wildes CP, 
et al. Structures of human Bruton's tyrosine kinase in active and inactive 
conformations suggest a mechanism of activation for TEC family kinases. 
Protein Sci. 2010;19(3):429-39.  
21. Yang L, Song G, Carriquiry A, Jernigan RL. Close correspondence 
between the motions from principal component analysis of multiple HIV-1 
protease structures and elastic network modes. Structure. 2008;16(2):321-30.  
	   107	  
22. Mustafa M, Mirza A, Kannan N. Conformational regulation of the EGFR 
kinase core by the juxtamembrane and C-terminal tail: a molecular dynamics 
study. Proteins. 2011;79(1):99-114.  
23. Cheng Y, Zhang Y, McCammon JA. How does activation loop 
phosphorylation modulate catalytic activity in the cAMP-dependent protein 
kinase: a theoretical study. Protein Sci. 2006;15(4):672-83.  
24. Lu B, Wong CF, McCammon JA. Release of ADP from the catalytic 
subunit of protein kinase A: a molecular dynamics simulation study. Protein 
Sci. 2005;14(1):159-68.  
25. Bahar I, Rader AJ. Coarse-grained normal mode analysis in structural 
biology. Curr Opin Struct Biol. 2005;15(5):586-92.  
26. Kim MK, Chirikjian GS, Jernigan RL. Elastic models of conformational 
transitions in macromolecules. J Mol Graph Model. 2002;21(2):151-60. Epub 
2002/10/26. PubMed PMID: 12398345. 
27. McClendon CL, Kornev AP, Gilson MK, Taylor SS. Dynamic architecture 
of a protein kinase. Proc Natl Acad Sci U S A. 2014;111(43):E4623-31.  
28. Johnson DA, Akamine P, Radzio-Andzelm E, Madhusudan M, Taylor SS. 
Dynamics of cAMP-dependent protein kinase. Chem Rev. 2001;101(8):2243-
70.  
29. Freeman LC. Centrality in social networks conceptual clarification. Social 
Networks. 1978;1(3):215-39.  
	   108	  
30. Freeman LC, Borgatti SP, White DR. Centrality in valued graphs: A 
measure of betweenness based on network flow. Social Networks. 
1991;13(2):141-54.  
31. Banavali NK, Roux B. The N-terminal end of the catalytic domain of SRC 
kinase Hck is a conformational switch implicated in long-range allosteric 
regulation. Structure. 2005;13(11):1715-23.  
32. James KA, Verkhivker GM. Structure-based network analysis of 
activation mechanisms in the ErbB family of receptor tyrosine kinases: the 
regulatory spine residues are global mediators of structural stability and 
allosteric interactions. PLoS One. 2014;9(11):e113488.  
33. Tse A, Verkhivker GM. Molecular Dynamics Simulations and Structural 
Network Analysis of c-Abl and c-Src Kinase Core Proteins: Capturing 
Allosteric Mechanisms and Communication Pathways from Residue Centrality. 
J Chem Inf Model. 2015.  
34. Srivastava AK, McDonald LR, Cembran A, Kim J, Masterson LR, 
McClendon CL, et al. Synchronous opening and closing motions are essential 
for cAMP-dependent protein kinase A signaling. Structure. 2014;22(12):1735-
43.  
35. Joseph RE, Kleino I, Wales TE, Xie Q, Fulton DB, Engen JR, et al. 
Activation loop dynamics determine the different catalytic efficiencies of B 
cell- and T cell-specific tec kinases. Sci Signal. 2013;6(290):ra76.  
	   109	  
36. Skora L, Mestan J, Fabbro D, Jahnke W, Grzesiek S. NMR reveals the 
allosteric opening and closing of Abelson tyrosine kinase by ATP-site and 
myristoyl pocket inhibitors. Proc Natl Acad Sci U S A. 2013;110(47):E4437-45.  
37. del Sol A, Tsai CJ, Ma B, Nussinov R. The origin of allosteric functional 
modulation: multiple pre-existing pathways. Structure. 2009;17(8):1042-50.  
38. Kornev AP, Taylor SS. Dynamics-Driven Allostery in Protein Kinases. 
Trends Biochem Sci. 2015;40(11):628-47.  
39. Girvan M, Newman ME. Community structure in social and biological 
networks. Proc Natl Acad Sci U S A. 2002;99(12):7821-6.  
40. Scarabelli G, Grant BJ. Kinesin-5 allosteric inhibitors uncouple the 
dynamics of nucleotide, microtubule, and neck-linker binding sites. Biophys J. 
2014;107(9):2204-13.  
41. Ghosh A, Sakaguchi R, Liu C, Vishveshwara S, Hou YM. Allosteric 
communication in cysteinyl tRNA synthetase: a network of direct and indirect 
readout. J Biol Chem. 2011;286(43):37721-31.  
42. Linton CF. A Set of Measures of Centrality Based on Betweenness. 
Sociometry. 1977;40(1):35-41.  
43. Micheletti C. Comparing proteins by their internal dynamics: exploring 
structure-function relationships beyond static structural alignments. Phys Life 
Rev. 2013;10(1):1-26.  
44. Haliloglu T, Bahar I. Adaptability of protein structures to enable functional 
interactions and evolutionary implications. Curr Opin Struct Biol. 2015;35:17-
23.  
	   110	  
45. Joseph RE, Andreotti AH. Bacterial expression and purification of 
interleukin-2 tyrosine kinase: single step separation of the chaperonin impurity. 
Protein Expr Purif. 2008;60(2):194-7. 
46. Wales TE, Fadgen KE, Gerhardt GC, Engen JR. High-speed and high-
resolution UPLC separation at zero degrees Celsius. Anal Chem. 
2008;80(17):6815-20.  
47. Houde D, Berkowitz SA, Engen JR. The utility of hydrogen/deuterium 
exchange mass spectrometry in biopharmaceutical comparability studies. J 
Pharm Sci. 2011;100(6):2071-86.  
48. Ogawa A, Takayama Y, Sakai H, Chong KT, Takeuchi S, Nakagawa A, et 
al. Structure of the carboxyl-terminal Src kinase, Csk. J Biol Chem. 
2002;277(17):14351-4.  
49. Yamaguchi H, Hendrickson WA. Structural basis for activation of human 
lymphocyte kinase Lck upon tyrosine phosphorylation. Nature. 
1996;384(6608):484-9.  
50. Mao C, Zhou M, Uckun FM. Crystal structure of Bruton's tyrosine kinase 
domain suggests a novel pathway for activation and provides insights into the 
molecular basis of X-linked agammaglobulinemia. Journal of Biological 
Chemistry. 2001;276(44):41435-43.  
51. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, et al. 
Scalable molecular dynamics with NAMD. J Comput Chem. 
2005;26(16):1781-802.  
	   111	  
52. MacKerell AD, Jr., Banavali N, Foloppe N. Development and current 
status of the CHARMM force field for nucleic acids. Biopolymers. 
2000;56(4):257-65.  
53. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J 
Mol Graph. 1996;14(1):33-8, 27-8.  
54. DeLano WL. Pymol: An open-source molecular graphics tool. CCP4 
Newsletter On Protein Crystallography. 2002;40:82-92. 
55. Grant BJ, Rodrigues AP, ElSawy KM, McCammon JA, Caves LS. Bio3d: 
an R package for the comparative analysis of protein structures. 
Bioinformatics. 2006;22(21):2695-6. 
56. Ihaka R, Gentleman R. R: A Language for Data Analysis and Graphics. 
Journal of Computational and Graphical Statistics. 1996;5(3):299-314.  
 
 
 
 
 
 
 
 
 
 
 
	   112	  
Figures 
 
 
 
Fig. 1. W395 is required for Btk activity.  
(a) Btk linker-kinase domain structure (PDB ID: 3K54) showing the 
linker, N- and C-lobes, active site, and activation segment. (b) Key regulatory 
elements in the Btk linker-kinase domain are the R- and C-spines, orange and 
yellow, respectively. ATP completes the C-spine structure in the N-lobe but is 
omitted here for clarity. W395 is shown above the aC-helix and the residues 
in the conserved salt bridge, K430 and E445 are labeled.  The C- and R-
spines are supported by the αF-helix in the C-lobe of the kinase domain. (c) 
Initial velocity measurements comparing the activity of full-length Btk (domain 
structure is shown to the right) to full-length Btk (W395A) using the poly (4:1, 
Glu:Tyr) peptide substrate11.  
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Fig. 2. HDXMS reveals greater conformational sampling for active Btk linker-
kinase domain.  
(a) Constructs used for activity assays and HDXMS study. The 
underlined residue is vector derived and not part of the sequence of the Btk 
kinase domain. Both Btk linker-kinase and Btk (W395A) linker-kinase carried 
a hexahistidine tag (6His) at the C-terminus. (b) Western blot assay to probe 
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phosphorylation of the Btk activation loop Y551 and Y783 in the PLCγ1 
substrate. Anti-His antibody recognizes the 6-His tag on the Btk constructs 
and is used to detect the amount of Btk enzyme in each reaction.   (c) 
Differences greater than 0.7 Da at any one of the five time points between 10 
seconds and 4 hours in the hydrogen-deuterium exchange experiment are 
mapped onto two depictions of the Btk linker-kinase domain (PDB ID: 3GEN) 
and colored in blue.  The side chain of W395 is red and labeled. (d-e) 
Deuterium exchange for peptides derived from the αC-helix and activation 
segment in Btk linker-kinase (red) and Btk (W395A) linker-kinase (blue). (f) 
Deuterium exchange for peptides derived from the linker and N-terminal 
region of Btk linker-kinase (red) and Btk (W395A) linker-kinase (blue). 
Complete HDX data is provided in Supp. Fig. S1. (g) Side-chain rotamer 
conformations of W395 in the structures of active (3K54) and inactive (3GEN) 
Btk linker-kinase.  
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Fig. 3. MD simulations of Btk linker-kinase and Btk (W395A) linker-kinase 
domains.  
Three replicates (200 nanosecond (ns) each) equilibrium simulations 
(black/ grey/light grey traces) were performed for Btk linker-kinase ((a), 
superimposed) and (W395A) linker-kinase domains (b,c,d). RMSD from the 
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starting structure is reported for the backbone atoms (total), activation 
segment (540-547) and αC-helix (439-451). The distance (Å) between the 
side-chains of K430 and E445 is shown over the course of the simulations. 
The red dashed lines in each plot are included for ease of comparison 
between mutant and wild type trajectories.  (e,f) Snapshots of structures from 
the wild type Btk linker-kinase simulation at 0 and 200 ns (e) and from the Btk 
(W395A) linker-kinase simulation at 0, 10 and 200 ns (f).  The wild type Btk 
linker-kinase domain retains the active conformation throughout the 200 ns 
simulation.  The K430/E445 salt bridge distance is indicated and the 
interaction between R544 and pY551 is evident at the beginning and end of 
the simulation. Btk (W395A) linker-kinase domain starts in the active 
conformation but moves toward the inactive state as early as 10 ns.  Further 
transition to the inactive conformation (‘C-out’) is observed as the simulation 
progresses and at 200 ns the K430/E445 distance is 14.5Å and R544 
contacts the side chain of E445 rather than pY551.  F540 is shown at 0 and 
200 ns in the Btk (W395A) linker-kinase structures to illustrate the shift from 
the active DFG conformation to inactive. 
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Fig. 4. Principle Component Analysis.  
(a,c) Percent variance captured by the first 10 PCs in Btk linker-kinase 
(a) and Btk (W395A) linker-kinase (c) domains. The red line is the cumulative 
variance captured by the PCs and the black line is the percentage of the 
variance captured by each individual PC. (b,d) Direction of motions in PC1, 
PC2 and PC3 for Btk linker-kinase (b) and Btk (W395A) linker-kinase (d) 
domain. Dotted lines show the axis of motion, the length of the vectors show 
the relative magnitudes and the arrowheads indicate the direction of motion.   
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Fig. 5. Community analysis.   
The community network in Btk linker-kinase (a) and Btk (W395A) 
linker-kinase (b) domains. (a,b left panel) The area of the circle indicates the 
number of residues within each community and the weight of the lines 
connecting communities is proportional to the extent of correlation between 
communities. (middle panel) Communities of residues mapped onto the Btk 
linker-kinase domain structure for Btk linker-kinase (a) and Btk (W395) linker-
kinase (b). (right panel) R-spine communities for the Btk linker-kinase 
simulation (a) and the Btk (W395A) linker-kinase simulation (b).  
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Fig. 6. Node-betweenness centrality index values reveals residues that bridge 
the R- and C-spines.  
(a-c) Node-betweenness centrality index plot for Btk linker-kinase (a), 
Btk (W395A) linker-kinase domains (b) and Lck kinase domain (c). The 
threshold (dotted line) was set for Btk linker-kinase (a), such that 98.5% of the 
centrality index values are below the threshold value. The same threshold is 
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used for Btk (W395A) linker kinase in (b) and Lck in (c). In (a) and (c) the 
centrality value for one residue, A428 in Btk and A271 in Lck, nearly reaches 
the threshold but was not included in our analysis since this residue is part of 
the previously defined C-spine in both kinases. (d) High centrality residues 
from (a) are mapped onto the structure of active Btk (3K54), labeled, and 
colored red. C-spine residues are yellow and R-spine residues are orange as 
in Fig. 1b. (e) Spheres define the residues of the C-spine (yellow), R-spine 
(orange) and the newly identified bridging residues (red). The αF-helix is 
shown and ATP within the C-spine is depicted in stick form. The communities 
(Fig. 5) of each of the four bridging residues are indicated. (f) High centrality 
residues in Lck (shown in (c)) are mapped onto the structure of the active Lck 
kinase domain (3LCK), labeled and colored red. As in (e) Lck C-spine 
residues are yellow and R-spine residues are orange, the αF-helix is shown 
and ATP is shown in stick form. I370 and L371 are high centrality residues in 
Lck (see (c)) and are part of the previously defined C-spine and therefore 
colored yellow. 
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Supplementary Figures 
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Supp. Fig. 1. HDXMS profile for peptides derived from Btk linker-kinase and 
Btk (W395A) linker-kinase domain. 
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Supp. Fig. 2. PCA: Btk (linker) kinase domain. 
Percentage of variance captured by the first 10 Principal Components 
(PC) in replicate 2 (a) and replicate 3 (b) for the Btk linker- kinase domain. 
The red line is the cumulative variance captured by the PCs and the black line 
is the percentage of the variance captured by each individual PC. Directions 
of motion for the first three PCs for the second (a) and third replicate (b) of 
Btk linker-kinase are shown alongside the percent variance plot. The length of 
the vectors show the relative magnitudes and the arrowheads indicate the 
direction of motion. (c) The PC scatter plots showing the projections of the 
conformations along PC1 and PC2 space, for the first, second and third 
replicates of Btk linker-kinase domain are shown. The color bar indicates 
simulation timescale. 
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Supp. Fig. 3. PCA: Btk (W395A) linker-kinase domain. 
 Percentage of variance captured by the first 10 Principal Components 
(PCs) in replicate 2 (a) and replicate 3 (b) for the Btk (W395A) linker-kinase 
domain. The red line is the cumulative variance captured by the PCs and the 
black line is the percentage of the variance captured by each individual PC. 
Directions of motion for the first three PCs for the second (a) and third 
replicate (b) of Btk (W395A) linker-kinase are shown alongside the percent 
variance plot. The length of the vectors show the relative magnitudes and the 
arrowheads indicate the direction of motion. (c) The PC scatter plots showing 
the projections of the conformations along PC1 and PC2 space, for the first, 
second and third replicates of Btk (W395A) linker-kinase domain are shown. 
The color bar indicates simulation timescale. 
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Supp. Fig. 4a-f. Overlap of PCs. 
Overlap between the first 10 PCs for replicate 1 and 2 (a) replicate 1 
and 3 (b) and replicate 2 and 3 (c) for Btk linker-kinase domain simulation. 
Overlap between the first 10 PCs for replicate 1 and 2 (d) replicate 1 and 3 (e) 
and replicate 2 and 3 (f) for Btk (W395A) linker-kinase domain simulation. The 
grey bar indicates the degree of overlap.  
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Supp. Fig. 4g-m. PC scatter plot of combined trajectories of Btk linker-kinase 
and Btk (W395A) linker-kinase domain in the same subspace. 
Projections of PC scores derived from combining all the simulation 
replicates of Btk linker-kinase and Btk (W395A) linker-kinase domain in the 
PC1-PC2-PC3 subspace are shown in (g). The projections of replicates 1, 2, 
3 of Btk (W395A) linker-kinase domain in PC1-PC2-PC3 subspace are shown 
in (h), (i), (j) respectively. The projections of replicates 1, 2, 3 of Btk linker-
kinase domain in PC1-PC2-PC3 subspace are shown in (k), (l), (m) 
respectively. The black filled circle in each scatter plot indicates the starting 
structure of the simulation trajectory. (In (k) the starting structure is indicated 
with a white circle.) The colorbar indicates the simulation replicates of Btk 
linker-kinase and Btk (W395A) linker-kinase domain. 
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Supp. Fig. 5. Dynamic Cross-Correlation maps: Btk linker-kinase and Btk 
(W395A) linker-kinase domains.                                                      
Covariance matrix of Cα atom pairs within 10 Å in the Btk linker-kinase 
domain (a) and Btk (W395A) linker-kinase domain (b) represented by the 
Dynamic Cross-correlation map (DCCM). The color bar indicates the degree 
of correlation. Red indicates large positive correlations and blue large 
negative correlations. The secondary structural elements in the Btk kinase 
domain are shown above each DCCM.   
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Supp. Fig. 6. Edge weights between communities. 
Weights of the edges between communities from community analysis 
of Btk linker-kinase domain (a). Weights of the edges between communities 
from community analysis of Btk (W395A) linker-kinase domain (b). 	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Supp.	  Fig.	  7.	  Community	  Analysis:	  Btk	  linker-­‐kinase	  domain.	  	  
	  
ComA (red) in Btk linker-kinase domain consists of W395, the 
Regulatory spine (R-spine) residue L460, Catalytic spine (C-spine) residues 
V416 and A428 and the gatekeeper residue T474 as well as the bridging 
residue Y476. It extends from residues 392-431 and 459-476. For all 
communities, the complete kinase domain is shown on the left and a close-up 
of the specific community is shown on the right.  These residues constitute 
the beta strands β1, β2, β3, β4, β5, and the Gly-rich loop. ComA is involved in 
positioning ATP in the active site and coordinating dynamics among the 
structural elements of the N-lobe. ComA also contains K430, which 
participates in a critical salt-bridge with E445 present on the αC-helix. W395 
presence in ComA signifies its role in the active site arrangement in Btk 
linker-kinase domain. 
W395
L460T474
W395
L460T474
αC-helix
β1
β2
β3
β4
β5
V416
A428
Gly-rich loop
V416
A428
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K430
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ComC (yellow) is localized on the αC-helix and constitutes residues 
432-452. It includes the R-spine residue M449. αC-helix is a critical regulatory 
unit, whose motion from the ‘C-in’ to the ‘C-out’ state mediates the status of 
the K430-E445 salt-bridge. The αC-helix is found to be a signal integration 
unit as its motion is coordinated with other critical structural units and thus 
promotes transmission of allostery to the active site from distant regions of 
the kinase domain. 
	  	  
αC-helix
M449
E445
M449
E445
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ComD (green) consists of the C-spine residues L482, C527 and L528 
as well as the proposed bridging residue M477 and L522. It includes residues 
453-458, 477-493 from the αD-helix as well as residues 521-539. 	  
	  	  
ComE (dark grey) is localized on the αE-helix. It includes residues from 494-
511.  
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ComP (pink) includes the R-spine residues H519 and F540. It includes 
residues from the catalytic loop 512-520 as well as residues from the 
activation segment N-terminus 540-545. 
	  
ComP’ (cyan) consists of residues from the C-terminus of the activation loop 
(546-555).  	   	  
 
F540
H519
F540
H519 αE-helix
activation segment
catalytic
 loop
activat
ion 
loop
	   136	  
	  
ComP2 (purple) consists of residues from the c-terminus of activation 
segment extending from 556-561, αEF-helix residues 563-575 and 636-637. 
	  
ComG (magenta) is localized on the αG-helix and the c-terminus of the 
αF-helix. It includes residue 562, 586-622. It includes the C-spine residues 
L586 and I590. 	  
 
αEF-helix
C-terminus 
activation 
segment
L586I590
L586I590
αG-helix
αF-helix
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ComF (orange) consists of R-spine reside D579 and the proposed 
bridging residue F583. It includes residues 576-585, 623-635, 638-644 and 
646-647. 	  
	  	  
ComI (pale orange) is localized on the αI-helix. It includes residue 645, 648-
659. 	  	  
	  
D579
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D579
F583 αF-helix
αH-helix
αI-
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Community Analysis: Btk (W395A) linker-kinase domain.  	  
	  
ComL (dark blue) consists of linker residues, which includes the A395 
mutation as well as residues from the αC-helix, including the salt-bridge 
forming E445. It extends from residues 392-396, 433-447 as well as 450.  
 
	  
ComA (red) includes the gatekeeper residue T474, salt-bridge forming 
residue K430, C-spine residues V416 and A428 as well as the high centrality 
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E445
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T474
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residue Y476. It includes residues from 397-432, 461-477 as well as residue 
479.	  	  
	  
ComE (dark grey) includes R-spine residues M449, L460, H519 and 
F540 as well as C-spine residues C527 and L528. It includes residues 448-
449, 451-460, 504-523, 526-543. 
	  
ComP (pink) is centered on the activation loop residues. It includes residues 
544-550. 
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ComF (orange) is localized on the αF-helix, αG-helix, αEF-helix, the c-
terminus of the activation segment and the αH-helix. It includes the R-spine 
residue D579. It includes residues extending from 551-585, 596-617 and 631-
647. 
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ComI (pale orange) is centered on the αI-helix and includes residues 
from αD, αE, αF-helices. It includes the C-spine residues L482, L586 and 
I590 as well as the high centrality residue G480. It includes residues 480-503, 
524-525, 586-595, 618-630, and 648-659. 
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CHAPTER 4: RESCUING BTK KINASE ACTIVITY IN THE PRESENCE OF 
AN XLA CAUSING MUTATION 
 
Manuscript in preparation 
Kejue Jia, Nikita Chopra, Amy H. Andreotti, Robert L. Jernigan  
 
Abstract 
X-linked agammaglobulinemia or XLA is an immunodeficiency disorder 
characterized by the absence of circulating mature B-cells, leading to 
increased susceptibility to numerous bacterial infections. It is caused by 
mutations found in a single protein called Bruton’s tyrosine kinase (Btk). Btk 
plays a critical role in immune signaling pathways in B-cells and the absence 
of Btk leads to defects in B-cell maturation and function. In this work, we 
focus on a common and severe form of XLA caused by mutation of R641 to 
histidine. We use extensive sequence information available for protein 
tyrosine kinases to identify a co-evolving site, which could be targeted to 
rescue Btk kinase activity in the presence of R641H. We have used the 
information theory approach, Symmetrized Differential Interaction Information, 
to identify residues co-evolving with R641. This approach, combined with all-
atom molecular dynamic simulations, has shown that substitution of a specific 
arginine at an allosteric site is capable of rescuing Btk activity in the presence 
of R641H mutation, in silico.    
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Introduction 
Bruton’s agammaglobulinemia or X-linked agammaglobulinemia (XLA) 
is an inherited severe immunodeficiency disorder1,2 characterized by the loss 
of circulating mature B-cells and immunoglobulins of all isotypes in the 
affected individual. This lead to an immune-compromised state, making the 
patients highly susceptible to bacterial infections1,2 such as S.pneumonia and 
H.influenzae.  
 
XLA has been attributed to mutations leading to the loss of activity of a 
protein tyrosine kinase Bruton’s tyrosine kinase or Btk1,2. Btk is a multi-
domain protein made up of an N-terminal Pleckstrin homology (PH), Tec 
homology (TH), Src homology 2 (SH2), Src homology 3 (SH3) and C-terminal 
kinase domain3. Btk activity has been found to be essential for B-cell 
maturation and function and loss of activity creates a block at the pre-B cell to 
pro-B cell developmental stage4. 
 
Btk’s role in immune cell signaling pathways in B-cells has been 
extensively studied3,5,6. It is activated upon antigen binding to the cell surface 
B-cell receptor, by Src family kinase member Lyn. Active Btk catalyzes the 
transfer of γ-phosphate group from ATP to Phospholipase C-γ2 (PLC-γ2). 
PLC-γ2 activity is required to cleave phosphatidylinositol-4,5-bisphosphate 
(PIP-2) to release second messengers inositol phosphate-3 (IP-3) and diacyl 
glycerol (DAG); IP-3 triggers release of Ca2+ ions from the endoplasmic 
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reticulum, while DAG activates Protein kinase C (PKC). This role of Btk in B-
cell receptor signaling is essential for B-cell function and maturation. 
 
The current treatment for XLA is aggressive and regular intravenous 
antibody therapy and bone marrow transplant. This treatment regime is cost 
limited. Our interest lies in identifying small molecules or cell permeable 
biologics, which could rescue Btk kinase activity in the presence of an XLA 
mutation. In pursuit of this aim, we are using the available sequence-structure 
information of Btk kinase to identify compensatory mutations that activate an 
XLA Btk mutant. Such allosteric sites would indicate regions that might serve 
as potential epitopes for developing highly specific small molecules that 
rescue the deleterious effects of the disease causing mutation. Identifying 
such an allosteric site would also reveal the molecular basis of XLA 
mutations, distant from the active site in Btk kinase.  
 
Our approach involves identifying a compensatory mutation, which can 
rescue Btk activity in the presence of an XLA causing mutation-R641H. The 
R641H substitution occurs at a highly conserved site in the C-lobe, ~28 Å 
away from the active site in Btk kinase and is one of the most severe XLA 
causing mutations identified in patients to date7.   
 
To identify allosteric sites, which could be targeted to rescue Btk 
activity, we used the sequence and structural information available for 
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kinases and used a novel method called Symmetrized Differential Interaction 
Information8 (SDII). SDII was first proposed to measure the interdependence 
between three of more variables, based on different shared properties such 
as co-evolution. In this study, we have used SDII to measure 
interdependence between three positions in the protein tyrosine kinase 
sequence alignment. The interdependence between these variables is 
derived from the co-evolution of amino acids. The amino acids, which were 
identified from this analysis as coevolving with R641, were mutated to other 
amino-acids occurring at the corresponding position in the sequence 
alignment and tested using long timescale all-atom molecular dynamics 
simulations.  
 
In this study, we have identified a specific site in the N-lobe of the 
kinase domain that rescues Btk kinase domain activity in the presence of the 
R641H XLA mutation in the C-lobe, in-silico. This site could serve as a 
putative target for designing small-molecules or peptides to rescue Btk 
R641H kinase activity. Our analysis also indicates a possible mechanism by 
which the R641H mutation affects Btk kinase domain activity. 
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Results 
All-atom Molecular Dynamics (MD) simulations capture the inactivating effect 
of the R641H mutation on Btk linker kinase domain. 
To determine whether MD simulations can be used to capture the 
inactivating effect of R641H on Btk, we compared the conformational 
preference of the Btk catalytic domain in the presence and absence of the 
R641H mutation. We used a construct of Btk kinase domain (Btk-linker kinase 
domain), consisting of residues from the SH2-linker kinase domain (392-659 
amino acids), for our studies as we have shown earlier that the isolated Btk 
kinase domain is inactive and a Trp395 residue in the SH2-linker kinase 
region is absolutely essential for Btk kinase domain activity9. Therefore, MD 
simulation of wild-type Btk-linker kinase domain was compared with Btk 
linker-kinase domain with the R641H mutation (referred to as Btk (R641H) 
linker-kinase domain).  
 
The conformational state of the kinase domain is assessed by 
monitoring the Root Mean Square Deviation (RMSD) of key structural 
elements and distance between key residues in the Btk kinase domain. The 
αC-helix is a critical structural motif, whose motion regulates the 
conformational state of Btk kinase domain. αC-helix samples a ‘C-in’ state in 
the active kinase domain (Fig. 1). This conformational state of the αC-helix 
facilitates the formation of a salt-bride between E445 on the αC-helix and 
K430 on the β3 strand in the kinase domain. An intact sat-bridge (K430-E445 
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distance < 4 Å) is required for the active kinase conformation as it positions 
the α and β phosphates of ATP for catalysis. In the inactive Btk kinase 
domain conformation, αC-helix samples a ‘C-out’ state, which causes K430-
E445 salt-bridge to break (K430-E445 distance > 4 Å). Therefore, RMSD of 
the αC-helix and distance between K430 and E445 are monitored throughout 
the MD simulation to determine the conformational state of Btk linker-kinase 
domain in the presence and absence of R641H mutation.  
 
Throughout the course of a 550 ns simulation, the wild-type Btk linker-
kinase domain samples conformation near its starting active conformation. 
There is no significant RMS change in the αC-helix from its starting state and 
therefore the αC-helix stays in the active ‘C-in’ state, keeping the critical salt-
bridge K430-E445 intact (Fig. 2a,b), thus maintaining the active-site 
machinery competent for catalysis. 
 
In the presence of the R641H mutation, however, the Btk linker-kinase 
domain deviates from its starting active conformation, and assumes hallmarks 
of an inactive kinase domain at ~50 ns in the course of a 550 ns simulation. 
The αC-helix RMS deviates from its starting active conformation, and as seen 
in the snapshots from MD simulations, the αC-helix moves from the active ‘C-
in’ to inactive ‘C-out’ state (Fig. 2a,b). This motion of the αC-helix increases 
the distance between K430 and E445, thus breaking the salt-bridge.  
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MD simulations, therefore, capture the shift in the conformational 
preference toward the inactive state of Btk linker-kinase domain in the 
presence of the XLA R641H mutation. It is interesting to see the long-range 
effects of this severe disease causing mutation present in the C-lobe; 
conformational changes are transmitted all the way to the αC-helix in the N-
lobe of the kinase domain. MD simulations, therefore, emerge as a useful tool 
to investigate the effects of XLA causing mutations in the kinase domain.     
 
Root mean square fluctuation differences between Btk linker-kinase and Btk 
(R641H) linker-kinase domains 
Root Mean Square Fluctuation (RMSF) indicates the average atomic 
mobility, indicating the stability of different regions of a protein.  RMSF was 
compared for different residues between Btk linker-kinase and Btk (R614H) 
linker-kinase domain over the course of the 550ns simulation (Fig. 3a).  In the 
N-lobe (amino acids 392-476), there is an increase in the atomic mobility in 
β1, β2, β3 (amino acids 401-409, 415-420, 424-430) strand residues in Btk 
(R641H) linker-kinase domain in comparison to the wild-type Btk linker-kinase 
domain, whereas there are decreased atomic fluctuations within the loop 
connecting β3 strand to the αC-helix (amino acids 431-440) (Fig. 3a,b). These 
differences in atomic mobility might contribute to the observed conformational 
preference of Btk (R641H) linker-kinase domain for the inactive state.   
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The activation segment at the junction of the N- and C-lobes (amino 
acids 550-565) also show differences in the RMSF in Btk linker and Btk 
(R641H) linker-kinase domains (Fig. 3a,b). The C-terminus of the activation 
segment shows greater atomic mobility in the Btk (R641H) linker-kinase 
domain in comparison to the wild-type active Btk linker-kinase domain, while 
atomic fluctuations are dampened in the N-terminus of the activation 
segment. 
 
In the C-lobe, RMSF differences are seen in the loop containing the 
R641 residue (Fig. 3a,b), wherein the mobility of the loop increases in the 
presence of histidine substitution in the mutant Btk (R641H) linker-kinase 
domain in comparison to the wild-type Btk linker-kinase domain. R641 in the 
native Btk kinase domain forms a salt-bridge with another highly conserved 
residue E567, which is present on the αEF-helix. Upon histidine substitution 
at 641 position, the R641-E567 salt bridge is lost and this contributes to the 
increased atomic fluctuations seen in this region in Btk (R641H) linker-kinase 
domain.      
 
Residues identified from SDII analysis as co-evolving with R641 
In order to identify compensatory mutations able to rescue Btk 
(R641H) linker-kinase domain activity, we employed the SDII method to 
identify mutual inter-dependence between the amino acid at position 641 and 
other positions in protein tyrosine kinase sequence alignment. The sequence 
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alignment set of protein tyrosine kinases derived from Pfam database was 
used as input for SDII calculations. Inter-dependence was calculated between 
three variables set which includes R641 and is based on their degree of co-
evolution. ~200 sets of residues were identified from SDII, which showed high 
co-evolutionary dependence on R641. A threshold was set for selecting 
amino acids for mutational studies such that 95% of SDII values are below 
the threshold. Therefore, the sets of amino acids with SDII value higher than 
the set threshold were selected for further analysis. The two high ranking 
residues with high SDII dependence with R641 are E567 and K430. R641 
makes a highly conserved salt-bridge with E567 in the C-lobe. K430 is also a 
functionally important residue as it forms the salt-bridge with E445 on the C-
helix in the N-lobe. Therefore, these two residues were not selected for 
mutational studies. The 8 next highest ranking set of residues, which had a 
strong dependence on R641 were then selected for mutational analysis (Fig. 
4a). The residues were mutated to the other amino acids occurring at the 
corresponding position in the sequence alignment. The mutations were then 
tested using short 20ns all-atom MD simulations in Btk (R641H) linker-kinase 
domain to determine whether they are able to rescue Btk linker-kinase 
domain dynamics in the presence of R641H mutation (Fig 4b). 
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K420R compensates for the loss of activity in the Btk (R641H) linker-kinase 
domain 
All-atom MD simulations of Btk (K420R/R641H) linker-kinase domain 
shows that K420R mutation stabilizes the Btk (R641H) linker-kinase domain 
in the active conformation, similar to the observed active conformation of the 
wild-type Btk linker-kinase domain (Fig. 5). Throughout the course of a 550 ns 
simulation, the αC-helix stayed in its starting active ‘C-in’ state, which is 
similar to the conformational preference seen in the wild-type Btk linker-
kinase domain. Consequently, the K430-E445 salt-bridge also stays intact 
throughout the course of the simulation.  
 
Similar atomic fluctuations seen in Btk linker and Btk (K420R/R641H) linker-
kinase domain RMSF plots. 
Strikingly similar behavior in the atomic mobility is seen between Btk 
linker and Btk (K420R/R641H) linker-kinase domain for Cα atoms in the N-
lobe (Fig. 6). Interestingly, the RMSF is similar for beta strands β2, β3, as well 
as the loop connecting the αC-helix and beta sheet within the N-lobe in Btk 
linker-kinase and Btk (K420R/R641H) linker-kinase domains. This is in 
contrast to the RMSF differences seen in this region between active Btk 
linker-kinase and inactive Btk (R641H) linker-kinase domain. 
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Regulatory spine residue F540 rotameric state is affected by the presence of 
the R641H mutation 
DFG-F540 samples the gauche(-) (g(-))  rotameric state in the active 
Btk kinase domain conformation. In the inactive kinase conformation, the chi1 
torsion angle of F540 changes to gauche (+) (g(+)), disassembling the R-
spine (Fig. 7). We investigated whether F540 chi1 changes from its active 
g(+) conformation in the presence of the R641H mutation; and indeed F540 
chi1 changes from the active g(-) to the g(+) rotameric state, which is 
characteristic of an inactive kinase domain. This rotameric change leads to 
disassembly of the R-spine in the kinase domain. However, the F540 samples 
the g(-) chi1 in Btk kinase domain in the double mutant R641H and K420R, 
throughout the course of 550 ns MD simulation (Fig 7).  
 
Discussion  
The challenge in the discovery of protein activators lies in identifying 
the site to target in the protein structure. It is usually approached using high-
throughput screening of available chemical libraries, which is limited by 
available resources. In silico tools can overcome the above stated challenges. 
Computational approaches can be used to narrow down the target site on the 
protein for screening for activators, which can then be experimentally 
evaluated. 
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The SDII approach helped us in narrowing down the target sites, which 
were tested for finding compensatory activating mutations. Of the eight target 
sites we have probed in silico, only the K420R substitution in the N-lobe could 
rescue the activity of Btk kinase domain in the presence of a debilitating XLA 
causing R641H mutation (Fig. 5). It is interesting to note, that of the 8 target 
sites we have probed using MD simulations, only K420, G423, A638 are at 
sites at which atomic fluctuations are different between Btk linker-kinase and 
Btk (R641H) linker-kinase domain simulations, while the remaining five 
residues lie at sites having similar atomic fluctuations. MD simulations show 
that mutation of the five residues, whose atomic fluctuations do not differ in 
Btk linker-kinase and Btk (R641H) linker-kinase domain simulations as well as 
A638T and G423V substitutions do not rescue Btk (R641H) linker-kinase 
domain from transitioning to it’s inactive conformation. A 550 ns long MD 
simulation of Btk (K420R/R641H) linker-kinase, however showed that the 
kinase domain is stabilized in it’s active conformation. RMSF comparison 
between Btk linker-kinase and Btk (K420R/R641H) linker-kinase domain 
showed that the atomic fluctuations are similar in the beta strands in the N-
lobe. We hypothesize that K420R might function by restoring atomic 
fluctuations in the N-lobe in the kinase domain, which are lost in the presence 
of the R641H mutation.  The difference in RMSF in the loop present in the C-
lobe where A638 is located, could be attributed to loss of the highly 
conserved R641H-E567K salt bridge (Fig. 8).  
 
	   154	  
Overall, the approach we have used in this work makes use of the rich 
information stored in the sequence data, which can be harvested to study the 
co-dependence between different regions of protein structure and to inform us 
effectively about a protein’s allostery. The observation we have made in silico, 
needs to be combined with experimental testing to further evaluate the activity 
of the Btk kinase in the presence of the R641H and K420R mutations. 
 
Materials and Method 
Protein kinase amino acid sequence data set alignment and refinement 
To identify co-evolutionary relationship between R641 and the 
remaining 266 amino acids in Btk kinase domain, we collected the sequence 
alignment set of protein tyrosine kinase family from Pfam (Pfam ID PF07714). 
Pfam is a repository of sequences of a large number of protein families. 
These sequences are stored in multiple sequence alignments format that 
were made by using a hidden Markov models (HMMs). There are 55024 
sequences from 676 species stored in Pfam family ID: PF07714 (referred to 
here as the raw data-set). To optimize the detection of co-evolutionary 
signals, the spurious correlations arising from redundant sequences in the 
raw data set were removed. In order to do that, we removed the sequences 
having 70% or greater sequence similarity (gaps are not included while 
evaluating sequence similarity). This data set includes 7953 sequences. 
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Symmetrized Differential Interaction Information (SDII) 
Symmetric differential interaction information is an information entropy 
based co-evolution signal detection method. It provides high order (n > 2) co-
evolution dependence among multiple residues. Interaction information can 
be written in terms of the summation of all the marginal and joint entropies of 
n variables 1 2 3, , ,...,{ }nX Xv XX=  : 
 
| |) ( 1) (( )
n
n
v
HI v τ
τ
τ
⊆
= − −∑
   
where τ  is the subset of v  and | |τ  is the cardinality of the subset. It is noted 
that the number of terms grows rapidly as a power of the number of variables. 
In order to detect co-evolutionary relationship between amino acids, the 
variables in the above calculation correspond to different positions in a 
multiple sequence alignment. The interaction information can be either 
positive or negative. This property makes it unsuitable for being an 
information measurement in the dependency analysis. To address this 
problem a new metric then is defined as the differential interaction 
information, Δ . It is the difference between values of successive interaction 
information by removing one variable from the set: 
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where { }iτ  is the set of all subset of nv  that contain iX . 
 
The differential interaction information is based on specifying one 
target variable. Its value is therefore asymmetric in that variable designation. 
To serve the purpose of detecting collective dependence among a variable 
set, a more general measure then is created by multiplying Δ s with all 
possible choices of the target variable. This construction restores the 
permutation symmetry of choosing variable. Finally the symmetric differential 
interaction information can be written as: 
 1 1
( ) ( 1) ) ( \{ })] ( 1) , )[ ((
n n
n n
n n n n i i n
i i
v I vv X vI X
= =
Δ = Δ = − − = − Δ∏ ∏
   
where, the product is over the choice of iX  and 2n >  . 
The set of three co-evolving residues (including R641 position) with highest 
SDII value, were then selected to be mutated to different amino acids 
occurring at that position in the sequence alignment. 
 
Structure preparation 
The coordinates of Btk linker-kinase (PDB ID: 3K5410, amino acids: 
392–659) were obtained from the RCSB PDB databank. The coordinates of 
the bound inhibitor were deleted from the PDB file. The regions missing from 
the electron density maps of 3K54 were modeled with the Loop Model module 
in MODELLER as follows: amino acids 435–441, which include the β3- αC 
loop and the N-terminus of the αC-helix, were modeled using Csk (PDB ID: 
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1K9A11, chain B) and Lck (PDB ID:3LCK12) as templates; amino acids 542–
558 which form the activation loop are modeled based on Btk (PDB 
ID:1K2P13) since 1K2P contains the activation loop resolved in the open 
conformation. Finally, none of the available crystal structures of Btk contain 
the DFG motif in the active conformation and so we used the structure of the 
active Lck kinase domain (PDB ID:3LCK) to model the active DFG-in 
conformation into Btk 3K54. The mutate_model module in Modeller was used 
to mutate R641 to histidine and K420 to arginine in Btk linker-kinase domain 
model to derive Btk (R641H) linker-kinase domain and Btk (R641H/K420R) 
linker-kinase domains. Phospho-Tyrosine patch TP2 was used to introduce 
phosphorylation of Y551 in both models. 
 
Simulation setup 
The NAMD 2.814 program with CHARMM27 force field was used to 
initiate all-atom MD simulations of Btk linker-kinase, Btk (R641H) linker-
kinase and Btk (R641H/K420R) linker-kinase domains. The proteins were 
solvated in a periodic water box with 15 Å buffering distance between protein 
surface and the box, using the TIP3P explicit water model. 150 mM 
concentration of ions (Na+ and Cl-) was added to charge neutralize the 
system. The systems were equilibrated and simulated in the NPT (Normal 
Pressure Temperature) ensemble at 310 K and 1 atm, using Particle-Mesh 
Ewald for long-range electrostatics. The cutoff used for the van der Waals 
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and short-range electrostatics calculations was 12 Å and hydrogen bonds 
were kept rigid using the ShakeH algorithm. The timestep used was 2 fs. 
The prepared simulation systems were minimized according to the 
following steps: (a) 20 picoseconds (ps) minimization of the entire system 
followed by 50 ps of equilibration by holding the protein rigid, allowing only 
water molecules and Na+ and Cl- ions to move. (b) The modeled loops which 
included the Gly-rich loop and the activation segment as well as the β3-αC-
helix loop were subjected to a very short minimization of 2 ps to remove any 
steric clashes. (c) The entire system was minimized, gradually releasing 
harmonic constraints on all protein heavy-atoms. The temperature of the 
system was then gradually raised from 200 K to 310 K with harmonic 
constraints on all protein heavy-atoms, in 5 K increments over a total of 90 ps. 
Subsequently, the harmonic constraints were gradually released and the 
system was equilibrated for a total time of approximately 1 ns. The production 
MD was run for 550 ns each.  
 
Trajectory analysis 
VMD15 was used to visualize the simulations trajectory and calculate 
Root Mean Square Deviation (RMSD) as well as salt-bridge and hydrogen-
bonding distances. For RMSD calculations, superposition is based on the C-
lobe (N479-S659) using the energy-minimized structure as a reference. 
MATLAB (The Mathworks, Inc.) was used to plot RMSD and distances 
obtained from VMD. Figures were generated with PyMOL.	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Figures 
 
Fig. 1. Anatomy of Btk linker-kinase domain 
The secondary structural elements are mapped on the crystal structure 
of Btk linker-kinase domain (PDB ID: 3K54). The zoomed in region shows the  
‘C-in’ and ‘C-out’ conformation of the αC-helix in the active and inactive Btk 
kinase domain, respectively (grey, PDB ID: 3K54, salmon, PDB ID:3GEN). 
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Fig.2. MD simulation of Btk linker-kinase and Btk (R641H) linker-kinase 
domains. 
(a) Root Mean Square deviation (RMSD) of key structural motifs in Btk 
linker-kinase (black) and Btk (R641H) linker-kinase (red) domains. (b) (c) 
Snapshot of Btk linker-kinase and Btk (R641H) linker-kinase domains 
showing key sequence and structural motifs, which were monitored 
throughout 550 ns simulation timescale.  
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Fig. 3. RMS fluctuations in Btk linker-kinase and Btk (R641H) linker-kinase 
domains simulations. 
(a) Root Mean Square fluctuations (RMSF) measuring the atomic 
fluctuations in Btk linker-kinase (black) and Btk (R641H) linker-kinase 
domains. (b) The differences in RMSF between Btk linker-kinase and Btk 
(R641H) linker-kinase domain are mapped in red on the snapshot derived 
from Btk (R641H) linker-kinase domain simulation. ATP is shown in sticks to 
indicate the active site in the Btk kinase domain. 
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(a) 	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(b) 
 
Fig. 4. Amino acids in Btk linker-kinase domain, identified using SDII which 
shows high co-evolutionary dependence on R641.  
(a) Residues showing high dependence on R641, as found by SDII 
calculations are shown on Btk linker-kinase domain. (b) 20ns MD simulations 
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of the selected mutations were carried out in Btk (R641H) linker-kinase 
domain, to probe for their compensatory effect. RMSD of the αC-helix and 
K430-E445 salt-bridge distance is monitored to determine the conformational 
state of Btk (R641H) linker-kinase domain in the presence of the selected 
mutations.  
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Fig. 5. MD simulations of Btk linker-kinase and Btk (K420R/R641H) linker-
kinase domains. 
RMSD of key structural motifs in Btk linker-kinase (black) (a) and Btk 
(K420R/R641H) linker-kinase (blue) domains. (b) Snapshot of Btk 
(K420R/R641H) linker-kinase domains showing key sequence and structural 
motifs, which were monitored throughout 550 ns simulation timescale.  
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Fig. 6. RMS fluctuations in Btk linker-kinase and Btk (K420R/R641H) linker-
kinase domains simulations. 
Root Mean Square fluctuations (RMSF) measuring the atomic 
fluctuations in Btk linker-kinase (black) and Btk (K420R/R641H) linker-kinase 
domains (blue). 
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Fig. 7. Rotamer sampling of F540 in Btk linker-kinase, Btk (R641H) linker-
kinase and Btk (K420R/R641H) linker-kinase domains simulations. 
DFG-F540 rotameric conformation at 0 and 550 ns simulation time-
points in Btk linker-kinase domain, Btk (R641H) linker-kinase domain, Btk 
(K420R) (R641H) linker-kinase domain. chi1 rotamer plot of DFG-F540 is 
monitored for 550 ns simulation timescale for Btk linker-kinase (black), Btk 
(R641H) linker-kinase (red) and Btk (K420R/R641H) linker-kinase domain 
(blue).  
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Fig. 8. Comparison of atomic fluctuations of target amino acids identified 
using SDII, in Btk linker-kinase and Btk (R641H) linker-kinase domains 
simulations.  
The high ranking co-evolving residues from SDII analysis, which were 
tested using MD simulations are mapped on the RMSF plot comparing atomic 
fluctuations in Btk linker-kinase and Btk (R641H) linker-kinase domains. The 
RMSF difference between Btk (R641H) linker-kinase and Btk linker-kinase 
domains is shown on top of every targeted residue. 
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CHAPTER 5: GENERAL CONCLUSIONS 
 
Summary 
There is a keen interest to understand Tec family kinase regulation, to 
further the knowledge of their role in immune signaling and decipher key 
structural motifs that regulate activity1,2.  It has been challenging, in part, due 
to the lack of a full-length crystal structure. In this dissertation, we have used 
extensive computational approaches combined with experimental methods to 
identify molecular determinants that regulate activity and shed light on their 
mechanisms in a member of Tec family of protein tyrosine kinase; Bruton’s 
tyrosine kinase or Btk3,4.  
 
In Chapter 2, we described the discovery of a molecular determinant, 
I432, in isolated Btk kinase domain, which contributes to its ‘inactive-by-
default’ status. We showed that the I432 imposes conformational restrictions 
within the Btk kinase domain to adopt the active conformation. We also 
showed that the conformational preference of the isolated Btk kinase domain 
could be shifted by substitution of I432 with leucine, which is found at the 
corresponding position in Src family of protein tyrosine kinase Lck. 
 
In Chapter 3 we have shown how a conserved residue, which lies 
outside the Btk kinase domain, functions to stabilize the active conformation5. 
Trp395, which lies in the SH2-linker region, is conserved at this position 
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among protein tyrosine kinases. We employed a novel statistical method to 
delineate the kinase domain into dynamically related regions, and showed 
that allostery mediated by Trp395 in Btk kinase domain involves long-range 
correlated motions. These correlated motions are lost in the inactive kinase 
domain in the absence of the Trp395 side-chain. We also identified ‘bridging 
residues’ which we hypothesize function to mediate communication between 
the two functionally important Regulatory and Catalytic spines. This work 
provides insight into the nature of allostery, indicating that there exist multiple 
allosteric communication pathways and that allostery can be mediated by 
dynamics within the protein. This is different from the alternate view of 
allostery, which is considered to be a linear path of communication and is 
mediated by a series of physically linked interactions.  
 
Chapter 4 is focused on the identification of allosteric sites, which 
could be targeted to rescue Btk kinase domain activity in the presence of an 
inactivating XLA mutation6. To date, there is no targeted therapy available for 
treatment of XLA disorders. We harvested the immense sequence data 
available and applied an approach called Symmetrized Differential Interaction 
Information7 to identify residues co-evolving with R641 in Btk.  Co-evolving 
sites are hypothesized to function in maintaining protein fold and mediating 
correlated dynamics in the protein structure. We have been able to identify an 
allosteric site, which could rescue Btk kinase domain activity in the presence 
of XLA causing R641H mutation in silico. It is a conservative mutation; K420R 
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and we have shown that the substitution of arginine at position 420 restores 
the atomic fluctuations in N-lobe of the Btk (R641H) linker kinase domain, 
stabilizing Btk kinase domain activity in the presence of the R641H mutation. 
This approach opens up doors to utilizing the available sequence data to 
identify co-evolution of amino acids in the protein structure and localize sites, 
which could be targeted for discovery of kinase activators.  
 
Future Directions 
The conformational restrictions imposed by I432 as discussed in 
Chapter 2, the changes in correlated motions on W395A mutation as 
discussed in chapter 3, and the differences in atomic fluctuations seen in N-
lobe in the presence of R641H mutation in C-lobe as seen in chapter 4, are 
not disparate features but are influenced by each other and tell us about the 
nature of dynamic allostery in kinases. For example, we noticed that in the 
presence of W395, I432 samples the trans rotamer for increased duration 
(40% of 200ns simulation timescale) in comparison with isolated Btk kinase 
domain. Also, in the presence of the R641H mutation, Trp395 samples a 
rotameric state as seen in the inactive Btk kinase domain. These 
observations suggest that small changes in any part of the kinase domain 
essentially change the dynamic vibrations within the protein. These dynamic 
vibrations in turn control activity. An elegant analogy drawn between Protein 
Kinase A and a violin12, by Alexandr Kornev and Susan Taylor at University of 
California, San Diego, further emphasis this point. Small localized changes on 
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the violin brought by change in hand position, changes the overall pitch by 
changing the vibrations of the entire instrument. Similarly, studies by our 
group as well as others, have shown that amino acid mutations at any part of 
the kinase domain, change long-range correlated motions and hence the 
activity. Further studies are needed to exploit dynamic allostery within protein 
kinases in order to develop selective modulators of their activity. 
 
Fig. 1: Dynamic allostery existing between different regulatory elements in Btk 
kinase domain compared to the violin model12 
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The section below further discusses specific directions in which we 
would like to pursue the above discussed projects. 
 
Identifying features which maintain Btk’s ‘inactive by default’ status 
 We have elucidated how combining molecular dynamics simulations 
with experimental methods can lead to identification of subtle molecular 
determinants such as I432, which shift the conformational preference of the 
Btk kinase domain towards the inactive state and towards the active state. 
Future work would involve discovering additional sequence/structural features 
which cooperate with I432 to maintain the ‘inactive-by-default’ status of 
isolated Btk kinase domain. NMR assignment of the Btk kinase domain is 
currently being pursued in our group, with the objective of understanding the 
communication between different regions of the Btk kinase domain. This 
understanding would help in focusing on allosteric sites, which could be 
targeted using small molecules or biologics. 
 
Elucidating the nature of allostery in protein kinase domain 
The discovery of bridging residues in chapter 3, is of immense interest 
to us. We have hypothesized, due to the location of these residues in the 
kinase domain, that they function to mediate the communication between the 
two functionally important Regulatory and Catalytic spines11. A mutational 
approach combined with NMR experiments, to test this hypothesis, is 
currently underway in our group. 
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We would also develop the community analysis method to extend it to 
study other mutations in Btk and other members of Tec family of kinases. We 
would like to extend the observation made by us and other research groups, 
that community analysis can detect dampening of long-range correlated 
motions in an inactive kinase domain conformation. Therefore, we would like 
to use this approach to screen for other disease-causing mutations in Btk, 
which lead to kinase domain inactivation. 
 
Discovering Btk kinase domain activators  
Finding protein activators is a challenging undertaking. Identifying co-
evolving sites with the targeted site of mutation is emerging as one of the 
approaches to identify regions that could then be targeted to rescue the 
activity of the protein in the presence of an inactivating mutation. This 
approach has shown that we can rescue Btk activity, in silico, in the presence 
of a severe XLA causing mutation. The ongoing work in the Andreotti lab 
focuses on experimentally testing the effect of the K420R compensatory 
mutation on Btk kinase with R641H mutation. It has also helped us to localize 
a putative site on Btk, which could be explored for drug discovery. We would 
also like to extend this approach to other XLA causing mutations, which 
inactivate Btk kinase.   
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